BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998;393:229-234. [PMID: 9607760 DOI: 10.1038/30400] [Cited by in Crossref: 615] [Cited by in F6Publishing: 594] [Article Influence: 25.6] [Reference Citation Analysis]
Number Citing Articles
1 Yu M, Zhang Q, Zhao X. Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review. Front Oncol 2022;12:973077. [DOI: 10.3389/fonc.2022.973077] [Reference Citation Analysis]
2 Chandra S, Goswami A, Mandal P. Molecular Heterogeneity of Cervical Cancer Among Different Ethnic/Racial Populations. J Racial Ethn Health Disparities 2021. [PMID: 34741276 DOI: 10.1007/s40615-021-01180-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Moniz CMV, Riechelmann RP, Oliveira SCR, Bariani GM, Rivelli TG, Ortega C, Pereira AAL, Meireles SI, Franco R, Chen A, Bonadio RC, Nahas C, Sabbaga J, Coudry RA, Braghiroli MI, Hoff PM. A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment Outcomes. J Cancer 2021;12:7018-25. [PMID: 34729104 DOI: 10.7150/jca.57678] [Reference Citation Analysis]
4 Chang YF, Yan GJ, Liu GC, Hong Y, Chen HL, Jiang S, Zhong Y, Xiyang YB, Hu T. HPV16 E6 Promotes the Progression of HPV Infection-Associated Cervical Cancer by Upregulating Glucose-6-Phosphate Dehydrogenase Expression. Front Oncol 2021;11:718781. [PMID: 34692493 DOI: 10.3389/fonc.2021.718781] [Reference Citation Analysis]
5 Rizzotto D, Englmaier L, Villunger A. At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity. Int J Mol Sci 2021;22:10883. [PMID: 34639222 DOI: 10.3390/ijms221910883] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
6 Visweswaran V, Jayamohanan H, Rajanbabu A, Pavithran K. Vulvar carcinoma in Fanconi Anaemia: A case report with review of literature. Gynecol Oncol Rep 2021;37:100841. [PMID: 34401436 DOI: 10.1016/j.gore.2021.100841] [Reference Citation Analysis]
7 Fang Y, Wu X, Li L, Zhu J, Wu H, Zhou H, He J, Wang Y. TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case-control study. Biosci Rep 2020;40:BSR20200854. [PMID: 32406493 DOI: 10.1042/BSR20200854] [Reference Citation Analysis]
8 Arizmendi-Izazaga A, Navarro-Tito N, Jiménez-Wences H, Mendoza-Catalán MA, Martínez-Carrillo DN, Zacapala-Gómez AE, Olea-Flores M, Dircio-Maldonado R, Torres-Rojas FI, Soto-Flores DG, Illades-Aguiar B, Ortiz-Ortiz J. Metabolic Reprogramming in Cancer: Role of HPV 16 Variants. Pathogens 2021;10:347. [PMID: 33809480 DOI: 10.3390/pathogens10030347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Vats A, Trejo-Cerro O, Thomas M, Banks L. Human papillomavirus E6 and E7: What remains? Tumour Virus Res 2021;11:200213. [PMID: 33716206 DOI: 10.1016/j.tvr.2021.200213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
10 Cao J, Chen Z, Tian C, Yu J, Zhang H, Yang J, Yang W. A Shared Susceptibility Locus in the p53 Gene for both Gastric and Esophageal Cancers in a Northwestern Chinese Population. Genet Test Mol Biomarkers 2020;24:804-11. [PMID: 33290139 DOI: 10.1089/gtmb.2020.0192] [Reference Citation Analysis]
11 Revathidevi S, Murugan AK, Nakaoka H, Inoue I, Munirajan AK. APOBEC: A molecular driver in cervical cancer pathogenesis. Cancer Lett 2021;496:104-16. [PMID: 33038491 DOI: 10.1016/j.canlet.2020.10.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
12 Dizaji BF, Farboudi A, Rahbar A, Azarbaijan MH, Asgary MR. The role of single- and multi-walled carbon nanotube in breast cancer treatment. Therapeutic Delivery 2020;11:653-72. [DOI: 10.4155/tde-2020-0019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
13 Khan MA, Tiwari D, Dongre A, Sadaf, Mustafa S, Das CR, Massey S, Bose PD, Bose S, Husain SA. Exploring the p53 connection of cervical cancer pathogenesis involving north-east Indian patients. PLoS One 2020;15:e0238500. [PMID: 32976537 DOI: 10.1371/journal.pone.0238500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
14 Shen CC, Cheng WY, Lee CH, Dai XJ, Chiao MT, Liang YJ, Hsieh WY, Mao TF, Lin GS, Chen SR, Liu BS, Chen JP. Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment. BMC Cancer 2020;20:709. [PMID: 32727419 DOI: 10.1186/s12885-020-07210-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Moreno-Acosta P, Romero-Rojas A, Vial N, Huertas A, Acosta J, Mayorga D, Carrillo S, Molano M, Gamboa O, Cotes M, Casadiego C, Vallard A, Magne N. Persistent High-Risk HPV Infection and Molecular Changes Related to the Development of Cervical Cancer. Case Rep Obstet Gynecol 2020;2020:6806857. [PMID: 33552605 DOI: 10.1155/2020/6806857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Barnoud T, Parris JLD, Murphy ME. Common genetic variants in the TP53 pathway and their impact on cancer. J Mol Cell Biol 2019;11:578-85. [PMID: 31152665 DOI: 10.1093/jmcb/mjz052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
17 Apu MNH, Rashed AZM, Bashar T, Rahman MM, Mostaid MS. TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study. Mol Biol Rep 2020;47:4357-64. [PMID: 32424519 DOI: 10.1007/s11033-020-05523-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Kamiza AB, Kamiza S, Singini MG, Mathew CG. Association of TP53 rs1042522 with cervical cancer in the sub-Saharan African population: a meta-analysis. Trop Med Int Health 2020;25:666-72. [PMID: 32233050 DOI: 10.1111/tmi.13397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kondakova IV, Shashova EE, Sidenko EA, Astakhova TM, Zakharova LA, Sharova NP. Estrogen Receptors and Ubiquitin Proteasome System: Mutual Regulation. Biomolecules 2020;10:E500. [PMID: 32224970 DOI: 10.3390/biom10040500] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
20 Liu P, Zhuo ZJ, Zhu J, Yang Z, Xin Y, Li S, Li L, Li Y, Wang H, He J. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study. J Gene Med 2020;22:e3182. [PMID: 32166848 DOI: 10.1002/jgm.3182] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
21 Đukić A, Lulić L, Thomas M, Skelin J, Bennett Saidu NE, Grce M, Banks L, Tomaić V. HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy? Pathogens 2020;9:E133. [PMID: 32085533 DOI: 10.3390/pathogens9020133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
22 Tramutola A, Falcucci S, Brocco U, Triani F, Lanzillotta C, Donati M, Panetta C, Luzi F, Iavarone F, Vincenzoni F, Castagnola M, Perluigi M, Di Domenico F, Marco F. Protein Oxidative Damage in UV-Related Skin Cancer and Dysplastic Lesions Contributes to Neoplastic Promotion and Progression. Cancers (Basel) 2020;12:E110. [PMID: 31906275 DOI: 10.3390/cancers12010110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Boon SS, Chen Z, Li J, Lee KYC, Cai L, Zhong R, Chan PKS. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly. BMC Cancer 2019;19:1211. [PMID: 31830929 DOI: 10.1186/s12885-019-6413-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Afzaljavan F, Chaeichi Tehrani N, Rivandi M, Zarif Ghasemian S, Vahednia E, Khayami R, Abavisani M, Pasdar A. The Dilemma of TP53 Codon 72 Polymorphism (rs1042522) and Breast Cancer Risk: A Case-Control Study and Meta-Analysis in The Iranian Population. Cell J 2020;22:185-92. [PMID: 31721533 DOI: 10.22074/cellj.2020.6458] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Wujcicka W, Zając A, Stachowiak G. Impact of MDM2, TP53 and P14ARF Polymorphisms on Endometrial Cancer Risk and Onset. In Vivo 2019;33:917-24. [PMID: 31028217 DOI: 10.21873/invivo.11559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
26 Rawat S, Yadav S, Mandloi P, Panihar C, Barde PV. High Incidence of Human Papillomavirus Types 16 and 18 in Cervical Carcinoma Patients in a Tertiary Care Unit, Jabalpur, MP, India. Indian J Gynecol Oncolog 2019;17. [DOI: 10.1007/s40944-019-0307-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Maru Y, Tanaka N, Ebisawa K, Odaka A, Sugiyama T, Itami M, Hippo Y. Establishment and characterization of patient-derived organoids from a young patient with cervical clear cell carcinoma. Cancer Sci 2019;110:2992-3005. [PMID: 31265190 DOI: 10.1111/cas.14119] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
28 Li L, Zhu J, Lu T, Liu W, Tang J, Zhang J, Wang Y, Li Y, Li S, Zhou H, Xia H, He J, Cheng J. Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers. Transl Oncol 2019;12:1282-8. [PMID: 31325764 DOI: 10.1016/j.tranon.2019.06.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
29 Rajitha B, Malla RR, Vadde R, Kasa P, Prasad GLV, Farran B, Kumari S, Pavitra E, Kamal MA, Raju GSR, Peela S, Nagaraju GP. Horizons of nanotechnology applications in female specific cancers. Semin Cancer Biol 2021;69:376-90. [PMID: 31301361 DOI: 10.1016/j.semcancer.2019.07.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
30 Ben Ayed I, Tounsi H, Jaballah A, Ardhaoui M, Maaloul A, Lassili T, Mezghani N, Abdelhak S, Boubaker S. Mucosal human papillomavirus detection and TP53 immunohistochemical expression in non-melanoma skin cancer in Tunisian patients. J Cutan Pathol 2019;46:591-8. [PMID: 30972814 DOI: 10.1111/cup.13473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Isakova J, Vinnikov D, Bukuev N, Talaibekova E, Aldasheva N. ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women. Asian Pac J Cancer Prev 2019;20:1057-62. [PMID: 31030474 DOI: 10.31557/APJCP.2019.20.4.1057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Forslund O, Sugiyama N, Wu C, Ravi N, Jin Y, Swoboda S, Andersson F, Bzhalava D, Hultin E, Paulsson K, Dillner J, Schwartz S, Wennerberg J, Ekblad L. A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin. BMC Cancer 2019;19:265. [PMID: 30909875 DOI: 10.1186/s12885-019-5469-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
33 Kuguyo O, Tsikai N, Thomford NE, Magwali T, Madziyire MG, Nhachi CFB, Matimba A, Dandara C. Genetic Susceptibility for Cervical Cancer in African Populations: What Are the Host Genetic Drivers? OMICS 2018;22:468-83. [PMID: 30004844 DOI: 10.1089/omi.2018.0075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
34 Paderno A, Morello R, Piazza C. Tongue carcinoma in young adults: a review of the literature. Acta Otorhinolaryngol Ital 2018;38:175-80. [PMID: 29984792 DOI: 10.14639/0392-100X-1932] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
35 Manoharan V, Karunanayake EH, Tennekoon KH, De Silva S, De Silva K, Angunawela P, Lunec J. Nucleotide variants and protein expression of TP53 in a Sri Lankan cohort of patients with head and neck cancer. Mol Med Rep 2019;19:2781-91. [PMID: 30816478 DOI: 10.3892/mmr.2019.9948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Lai TO, Boon SS, Law PT, Chen Z, Thomas M, Banks L, Chan PK. Oncogenicitiy Comparison of Human Papillomavirus Type 52 E6 Variants. J Gen Virol 2019;100:484-96. [PMID: 30676312 DOI: 10.1099/jgv.0.001222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
37 Han Y, Wu P, Wang Z, Zhang Z, Sun S, Liu J, Gong S, Gao P, Iwakuma T, Molina-Vila MA, Chen BP, Zhang Y, Ji T, Mo Q, Chen P, Hu J, Wang S, Zhou J, Lu H, Gao Q. Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation. EBioMedicine 2019;40:92-105. [PMID: 30674441 DOI: 10.1016/j.ebiom.2019.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
38 Liu GC, Zhou YF, Su XC, Zhang J. Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study. BMC Cancer 2019;19:24. [PMID: 30616520 DOI: 10.1186/s12885-018-5149-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
39 Stoehr R, Weisser R, Wendler O, Giedl J, Daifalla K, Gaisa NT, Richter G, Campean V, Burger M, Wullich B, Hartmann A. P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study. J Cancer 2018;9:4234-41. [PMID: 30519324 DOI: 10.7150/jca.26050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
40 Zhang Y, Zhang D, Zhao L, Sun L, Dong Q, Cheng L, Cheng R. Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis. Current Problems in Cancer 2018;42:582-92. [DOI: 10.1016/j.currproblcancer.2018.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
41 Sun Z, Gao W, Cui JT. Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis. BMC Oral Health 2018;18:143. [PMID: 30126398 DOI: 10.1186/s12903-018-0603-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Roshani D, Abdolahi A, Rahmati S. Association of p53 codon 72 Arg>Pro polymorphism and risk of cancer in Iranian population: A systematic review and meta-analysis. Med J Islam Repub Iran 2017;31:136. [PMID: 29951436 DOI: 10.14196/mjiri.31.136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Alsbeih G. Exploring the Causes of the Low Incidence of Cervical Cancer in Western Asia. Asian Pac J Cancer Prev 2018;19:1425-9. [PMID: 29936711 DOI: 10.22034/APJCP.2018.19.6.1425] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
44 Assad Samani L, Javadirad SM, Parsafar S, Tabatabaeian H, Ghaedi K, Azadeh M. TP53 rs1625895 is Related to Breast Cancer Incidence and Early Death in Iranian Population. Indian J Clin Biochem 2019;34:485-9. [PMID: 31686737 DOI: 10.1007/s12291-018-0774-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
45 Akhter N, Dar SA, Chattopadhyay S, Haque S, Anwer R, Wahid M, Jawed A, Lohani M, Mandal RK, Shukla NK, Abdul Y, Husain SA. Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population. Curr Genomics 2018;19:395-410. [PMID: 30065615 DOI: 10.2174/1389202919666171205104137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
46 Le X, Hanna EY. Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined. Ann Transl Med 2018;6:229. [PMID: 30023392 DOI: 10.21037/atm.2018.05.10] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
47 Coelho A, Nogueira A, Soares S, Assis J, Pereira D, Bravo I, Catarino R, Medeiros R. TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer. Oncol Lett 2018;15:8165-71. [PMID: 29731921 DOI: 10.3892/ol.2018.8354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Mascelli S, Nozza P, Jones DT, Colin C, Pistorio A, Milanaccio C, Ravegnani M, Consales A, Witt O, Morana G, Cama A, Capra V, Biassoni R, Pfister SM, Figarella-Branger D, Garrè ML, Raso A. TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma. Oncotarget 2016;7:47918-26. [PMID: 27374106 DOI: 10.18632/oncotarget.10295] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Cui N, Yang WT, Zheng PS. Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression. Oncotarget 2016;7:26152-67. [PMID: 27036045 DOI: 10.18632/oncotarget.8434] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
50 Devor EJ, Reyes HD, Gonzalez-Bosquet J, Warrier A, Kenzie SA, Ibik NV, Miller MD, Schickling BM, Goodheart MJ, Thiel KW, Leslie KK. Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology. Int J Gynecol Cancer 2017;27:784-90. [PMID: 28375929 DOI: 10.1097/IGC.0000000000000957] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
51 Park S, Yoon H, Bang H, Kim Y, Choi S, Ahn S, Kim J, Lee S, Yang JY, Lee D. Analytical Performance of Sensitivity and Specificity for Rapid Multiplex High Risk Human Papillomavirus Detection Kit: HPV ViroCheck. Korean J Clin Lab Sci 2017;49:446-54. [DOI: 10.15324/kjcls.2017.49.4.446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
52 Lahsen AO, Baba H, Bensghir R, Fayssel N, Sodqi M, Marih L, Nadifi S, Wakrim L, El Filali KM, Ezzikouri S. TP53 R72P Polymorphism and Susceptibility to Human Papillomavirus Infection Among Women With Human Immunodeficiency Virus in Morocco: A Case-control Study. J Cancer Prev 2017;22:248-53. [PMID: 29302583 DOI: 10.15430/JCP.2017.22.4.248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
53 Zhang A, Shi TY, Zhao Y, Xiang J, Yu D, Liang Z, Xu C, Zhang Q, Hu Y, Wang D, He J, Duan P. No association between TP53 Arg72Pro polymorphism and ovarian cancer risk: evidence from 10113 subjects. Oncotarget 2017;8:112761-9. [PMID: 29348863 DOI: 10.18632/oncotarget.22603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
54 Al-harbi NM, Bin Judia SS, Mishra KN, Shoukri MM, Alsbeih GA. Genetic Predisposition to Cervical Cancer and the Association With XRCC1 and TGFB1 Polymorphisms. Int J Gynecol Cancer 2017;27:1949-56. [DOI: 10.1097/igc.0000000000001103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
55 Habyarimana T, Attaleb M, Mugenzi P, Mazarati JB, Bakri Y, El Mzibri M. Association of p53 Codon 72 Polymorphism with Breast Cancer in a Rwandese Population. Pathobiology 2018;85:186-91. [PMID: 29131100 DOI: 10.1159/000481664] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
56 Hosseinpour Z, Salehi Z, Talesh Sasani S, Aminian K. p53 and miR-34b/c genetic variation and their impact on ulcerative colitis susceptibility. Br J Biomed Sci 2018;75:46-9. [PMID: 28934017 DOI: 10.1080/09674845.2017.1362729] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
57 Moschonas GD, Tsakogiannis D, Lamprou KA, Mastora E, Dimitriou TG, Kyriakopoulou Z, Kottaridi C, Karakitsos P, Markoulatos P. Association of codon 72 polymorphism of p53 with the severity of cervical dysplasia, E6-T350G and HPV16 variant lineages in HPV16-infected women. J Med Microbiol 2017;66:1358-65. [PMID: 28857739 DOI: 10.1099/jmm.0.000563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
58 Kenney AD, Dowdle JA, Bozzacco L, McMichael TM, St Gelais C, Panfil AR, Sun Y, Schlesinger LS, Anderson MZ, Green PL, López CB, Rosenberg BR, Wu L, Yount JS. Human Genetic Determinants of Viral Diseases. Annu Rev Genet 2017;51:241-63. [PMID: 28853921 DOI: 10.1146/annurev-genet-120116-023425] [Cited by in Crossref: 54] [Cited by in F6Publishing: 69] [Article Influence: 10.8] [Reference Citation Analysis]
59 Oba S, Toyoshima M, Ogata H. Association of Cervical Cancer Screening with Knowledge of Risk Factors, Access to Health Related Information, Health Profiles, and Health Competence Beliefs among Community-Dwelling Women in Japan. Asian Pac J Cancer Prev 2017;18:2115-21. [PMID: 28843231 DOI: 10.22034/APJCP.2017.18.8.2115] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
60 Aydin M, Bozkurt A, Cikman A, Gulhan B, Karabakan M, Gokce A, Alper M, Kara M. Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in Turkish men with prostate cancer. Int Braz J Urol 2017;43:36-46. [PMID: 28124524 DOI: 10.1590/S1677-5538.IBJU.2015.0429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
61 Bansal A, Das P, Kannan S, Mahantshetty U, Mulherkar R. Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India. Indian J Med Res 2016;144:359-65. [PMID: 28139534 DOI: 10.4103/0971-5916.198685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
62 Babakhani F, Azad TM, Kondori N, Jalilvand S, Mozhgani S, Ghavami N, Farzanehpour M, Babaei F. Detection of HPV genotypes and their association with p53 codon 72 polymorphism in prostate cancer. Future Virology 2017;12:275-81. [DOI: 10.2217/fvl-2017-0001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
63 Rao AKDM, Manikandan M, Arunkumar G, Revathidevi S, Vinothkumar V, Arun K, Tiwary BK, Rajkumar KS, Rajaraman R, Munirajan AK. Prevalence of p53 codon 72, p73 G4C14-A4T14 and MDM2 T309G polymorphisms and its association with the risk of oral cancer in South Indians. Gene Reports 2017;7:106-12. [DOI: 10.1016/j.genrep.2017.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
64 Chuery ACS, Silva IDCGD, Ribalta JCL, Speck NMDG. Association between the p53 arginine/arginine homozygous genotype at codon 72 and human papillomavirus E6/E7 mRNA expression. The Brazilian Journal of Infectious Diseases 2017;21:248-54. [DOI: 10.1016/j.bjid.2017.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
65 Alsbeih GA, Al-Harbi NM, Bin Judia SS, Khoja HA, Shoukri MM, Tulbah AM. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence. Cancer 2017;123:2459-66. [PMID: 28393355 DOI: 10.1002/cncr.30635] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
66 Elhawary NA, Nassir A, Saada H, Dannoun A, Qoqandi O, Alsharif A, Tayeb MT. Combined Genetic Biomarkers Confer Susceptibility to Risk of Urothelial Bladder Carcinoma in a Saudi Population. Dis Markers 2017;2017:1474560. [PMID: 28348449 DOI: 10.1155/2017/1474560] [Reference Citation Analysis]
67 Bestgen S, Seidl C, Wiesner T, Zimmer A, Falk M, Köberle B, Austeri M, Paradies J, Bräse S, Schepers U, Roesky PW. Double-Strand DNA Breaks Induced by Paracyclophane Gold(I) Complexes. Chem Eur J 2017;23:6315-22. [DOI: 10.1002/chem.201605237] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
68 Elhawary NA, Nassir A, Saada H, Dannoun A, Qoqandi O, Alsharif A, Tayeb MT. Combined Genetic Biomarkers Confer Susceptibility to Risk of Urothelial Bladder Carcinoma in a Saudi Population. Dis Markers 2017;2017:1474560. [PMID: 28348449 DOI: 10.1155/2017/1474560] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
69 Fu W, Zhuo ZJ, Jia W, Zhu J, Zhu SB, Lin ZF, Wang FH, Xia H, He J, Liu GC. Association between TP53 gene Arg72Pro polymorphism and Wilms' tumor risk in a Chinese population. Onco Targets Ther 2017;10:1149-54. [PMID: 28260929 DOI: 10.2147/OTT.S131014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
70 Yagnik G, Jahangiri A, Chen R, Wagner JR, Aghi MK. Role of a p53 polymorphism in the development of nonfunctional pituitary adenomas. Mol Cell Endocrinol 2017;446:81-90. [PMID: 28214592 DOI: 10.1016/j.mce.2017.02.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
71 Pillai RM, Nair SA. Polymorphism of p53 in cancer prognosis. Indian J Med Res 2016;144:314-6. [PMID: 28139528 DOI: 10.4103/0971-5916.198683] [Reference Citation Analysis]
72 Qvick A, Sorbe B, Helenius G, Karlsson MG, Lillsunde Larsson G. Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina? Med Oncol 2017;34:36. [PMID: 28144815 DOI: 10.1007/s12032-017-0893-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
73 Tandon N, Srivastava AN, Fatima N, Raza ST, Kumar V. p53 Codon 72 Gene Polymorphism Studies and p53 Expression by Immunohistochemistry in Oral Lesions as Risk Factor for Malignancy. Int J Appl Basic Med Res 2017;7:243-6. [PMID: 29308362 DOI: 10.4103/ijabmr.IJABMR_205_16] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Ramya AS, Majumdar S, Babu TM, Uppala D, Srinivas B, Rao AK. Expression of Human Papillomavirus DNA and p53 Polymorphisms through Polymerase Chain Reaction in Normal Mucosa and Oral Leukoplakia Individuals with Deleterious Oral Habits. Int J Appl Basic Med Res 2017;7:134-8. [PMID: 28584747 DOI: 10.4103/ijabmr.IJABMR_57_16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
75 Das P, Bansal A, Rao SN, Deodhar K, Mahantshetty U, Shrivastava SK, Sivaraman K, Mulherkar R. Somatic Variations in Cervical Cancers in Indian Patients. PLoS One 2016;11:e0165878. [PMID: 27829003 DOI: 10.1371/journal.pone.0165878] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
76 Severson J, Evans TY, Lee P, Chan T, Arany I, Tyring SK. Human Papillomavirus Infections: Epidemiology, Pathogenesis, and Therapy. J Cutan Med Surg 2001;5:43-60. [DOI: 10.1177/120347540100500110] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
77 Omori S, Yoshida S, Kennedy SH, Negoro K, Hamana S, Barlow DH, Maruo T. Polymorphism at Codon 72 of the p53 Gene Is Not associated With Endometriosis in a Japanese Population. Journal of the Society for Gynecologic Investigation 2016;11:232-6. [DOI: 10.1016/j.jsgi.2003.11.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
78 Meyrelles AR, Siqueira JD, Santos PP, Hofer CB, Luiz RR, Seuánez HN, Almeida G, Soares MA, Soares EA, Machado ES. Bonafide, type-specific human papillomavirus persistence among HIV-positive pregnant women: predictive value for cytological abnormalities, a longitudinal cohort study. Mem Inst Oswaldo Cruz 2016;111:120-7. [PMID: 26872340 DOI: 10.1590/0074-02760150393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
79 Sánchez E, Sabio JM, Callejas JL, de Ramón E, de Haro M, Jiménez-alonso J, Ortego-centeno N, Sánchez-román J, González-gay MA, López-nevot MA, González-escribano MF, Martín J. Study of a functional polymorphism in thep53 gene in systemic lupus erythematosus: lack of replication in a Spanish population. Lupus 2006;15:658-61. [DOI: 10.1177/0961203306070986] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
80 Mateos-Lindemann ML, Pérez-Castro S, Rodríguez-Iglesias M, Pérez-Gracia MT. Microbiological diagnosis of human papilloma virus infection. Enferm Infecc Microbiol Clin 2017;35:593-602. [PMID: 27353835 DOI: 10.1016/j.eimc.2016.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
81 Ostrow SL, Hershberg R. The Somatic Nature of Cancer Allows It to Affect Highly Constrained Genes. Genome Biol Evol 2016;8:1614-20. [PMID: 27190005 DOI: 10.1093/gbe/evw110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
82 Üren N, Korak T, Altınok D, Ergül E, Güllüoğlu B, Şimşek T, Cantürk Z, Utkan Z, Sazcı A. Meme Kanserinde TP53 (RS1042522) Polimorfizmi. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi 2016;2:28-31. [DOI: 10.30934/kusbed.358489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
83 Lin X, Hou D, Huang C, Luo X. The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis. Arch Gynecol Obstet 2016;294:353-9. [DOI: 10.1007/s00404-015-4005-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
84 Kibel AS, Ahn J, Isikbay M, Klim A, Wu WS, Hayes RB, Isaacs WB, Daw EW. Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma. Prostate 2016;76:479-90. [PMID: 26708993 DOI: 10.1002/pros.23139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
85 Chen P, Sun R, Pu Y, Bai P, Yuan F, Liang Y, Zhou B, Wang Y, Sun Y, Zhu J, Zhang L, Gao L. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study. Medicine (Baltimore) 2015;94:e1536. [PMID: 26402809 DOI: 10.1097/MD.0000000000001536] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
86 Cutilli T, Leocata P, Dolo V, Altobelli E. Association between p53 status, human papillomavirus infection, and overall survival in advanced oral cancer after resection and combination systemic treatment. Br J Oral Maxillofac Surg 2016;54:198-202. [PMID: 26669794 DOI: 10.1016/j.bjoms.2015.11.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
87 Yuan F, Sun R, Chen P, Liang Y, Ni S, Quan Y, Huang J, Zhang L, Gao L. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk. Tumour Biol 2016;37:6267-73. [PMID: 26619844 DOI: 10.1007/s13277-015-4467-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
88 Yadav P, Masroor M, Tanwer K, Mir R, Javid J, Ahmad I, Zuberi M, Kaza RC, Jain SK, Khurana N, Ray PC, Saxena A. Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients. Clin Transl Oncol 2016;18:728-34. [PMID: 26553387 DOI: 10.1007/s12094-015-1425-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
89 Zhou R, Wei C, Liu J, Luo Y, Tang W. The prognostic value of p53 expression for patients with cervical cancer: a meta analysis. Eur J Obstet Gynecol Reprod Biol 2015;195:210-3. [PMID: 26595307 DOI: 10.1016/j.ejogrb.2015.10.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
90 Montazeri Z, Theodoratou E, Nyiraneza C, Timofeeva M, Chen W, Svinti V, Sivakumaran S, Gresham G, Cubitt L, Carvajal-Carmona L, Bertagnolli MM, Zauber AG, Tomlinson I, Farrington SM, Dunlop MG, Campbell H, Little J. Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas. Int J Epidemiol 2016;45:186-205. [PMID: 26451011 DOI: 10.1093/ije/dyv185] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
91 Neamatzadeh H, Soleimanizad R, Atefi A, Zare-Shehneh M, Gharibi S, Shekari A, Rahimzadeh AB. Association between p53 codon 72 (Arg72Pro) polymorphism and primary open-angle glaucoma in Iranian patients. Iran Biomed J 2015;19:51-6. [PMID: 25605490 DOI: 10.6091/ibj.1379.2014] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
92 Sun Y, Zhang Y, Liu L, Song X, Li G. Genetic polymorphisms and HPV infection in oral squamous cell carcinomas. Current Opinion in Virology 2015;14:1-6. [DOI: 10.1016/j.coviro.2015.05.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
93 Volodko N, Salla M, Eksteen B, Fedorak RN, Huynh HQ, Baksh S. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development. World J Gastroenterol 2015; 21(36): 10358-10366 [PMID: 26420962 DOI: 10.3748/wjg.v21.i36.10358] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
94 Jiang E, Sun X, Kang H, Sun L, An W, Yao Y, Hu X. Dehydrocostus Lactone Inhibits Proliferation, Antiapoptosis, and Invasion of Cervical Cancer Cells Through PI3K/Akt Signaling Pathway. Int J Gynecol Cancer 2015;25:1179-86. [DOI: 10.1097/igc.0000000000000474] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
95 Niu YM, Du XY, Lu MY, Xu QL, Luo J, Shen M. Significant association between functional microRNA polymorphisms and head and neck cancer susceptibility: a comprehensive meta-analysis. Sci Rep 2015;5:12972. [PMID: 26277865 DOI: 10.1038/srep12972] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
96 Tan SC, Ankathil R. Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes. Tumour Biol. 2015;36:6633-6644. [PMID: 26242271 DOI: 10.1007/s13277-015-3868-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
97 Hou J, Gu Y, Hou W, Wu S, Lou Y, Yang W, Zhu L, Hu Y, Sun M, Xue H. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility. BMC Genet 2015;16:72. [PMID: 26123760 DOI: 10.1186/s12863-015-0235-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
98 Joo J, Yoon KA, Hayashi T, Kong SY, Shin HJ, Park B, Kim YM, Hwang SH, Kim J, Shin A, Kim JY. Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer. Cancer Res Treat 2016;48:708-14. [PMID: 26130668 DOI: 10.4143/crt.2015.098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
99 Ndiaye R, Dem A, Mbaye PM, Guèye PM, Diop G, Diop PA, Faye O. [Study of codon 72 of p53 gene as a risk-factor in cervical cancer in Senegal]. Bull Cancer 2014;101:789-94. [PMID: 25025520 DOI: 10.1684/bdc.2014.1911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
100 Ramakrishnan S, Partricia S, Mathan G. Overview of high-risk HPV's 16 and 18 infected cervical cancer: Pathogenesis to prevention. Biomedicine & Pharmacotherapy 2015;70:103-10. [DOI: 10.1016/j.biopha.2014.12.041] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
101 Hope CM, Coates PTH, Carroll RP. Immune profiling and cancer post transplantation. World J Nephrol 2015; 4(1): 41-56 [PMID: 25664246 DOI: 10.5527/wjn.v4.i1.41] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
102 Assoumou SZ, Boumba AL, Ndjoyi-Mbiguino A, Khattabi A, Ennaji MM. The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women. Med Oncol 2015;32:281. [PMID: 25502079 DOI: 10.1007/s12032-014-0281-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
103 Adduri RS, Katamoni R, Pandilla R, Madana SN, Paripati AK, Kotapalli V, Bashyam MD. TP53 Pro72 allele is enriched in oral tongue cancer and frequently mutated in esophageal cancer in India. PLoS One 2014;9:e114002. [PMID: 25436609 DOI: 10.1371/journal.pone.0114002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
104 Sina M, Pedram M, Ghojazadeh M, Kochaki A, Aghbali A. P53 gene codon 72 polymorphism in patients with oral squamous cell carcinoma in the population of northern Iran. Med Oral Patol Oral Cir Bucal 2014;19:e550-5. [PMID: 24880450 DOI: 10.4317/medoral.19794] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
105 Shterzer N, Heyman D, Shapiro B, Yaniv A, Jackman A, Serour F, Chaouat M, Gonen P, Tommasino M, Sherman L. Human papillomavirus types detected in skin warts and cancer differ in their transforming properties but commonly counteract UVB induced protective responses in human keratinocytes. Virology 2014;468-470:647-59. [PMID: 25443667 DOI: 10.1016/j.virol.2014.09.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
106 Panni S, Salvioli S, Santonico E, Langone F, Storino F, Altilia S, Franceschi C, Cesareni G, Castagnoli L. The adapter protein CD2AP binds to p53 protein in the cytoplasm and can discriminate its polymorphic variants P72R. J Biochem. 2015;157:101-111. [PMID: 25261582 DOI: 10.1093/jb/mvu059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
107 Djansugurova L, Zhunussova G, Khussainova E, Iksan O, Afonin G, Kaidarova D, Parker MI. Association of DCC, MLH1, GSTT1, GSTM1, and TP53 gene polymorphisms with colorectal cancer in Kazakhstan. Tumour Biol. 2015;36:279-289. [PMID: 25249451 DOI: 10.1007/s13277-014-2641-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
108 Michopoulou V, Derdas SP, Symvoulakis E, Mourmouras N, Nomikos A, Delakas D, Sourvinos G, Spandidos DA. Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients. Tumour Biol 2014;35:12765-73. [PMID: 25213701 DOI: 10.1007/s13277-014-2604-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
109 Entiauspe LG, Seixas FK, Nunes EM, Rodrigues FM, Dellagostin OA, Collares T, da Silveira MF. Uncommon non-oncogenic HPV genotypes, TP53 and MDM2 genes polymorphisms in HIV-infected women in Southern Brazil. Braz J Infect Dis 2014;18:643-50. [PMID: 25181402 DOI: 10.1016/j.bjid.2014.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
110 Kodaman N, Sobota RS, Mera R, Schneider BG, Williams SM. Disrupted human-pathogen co-evolution: a model for disease. Front Genet 2014;5:290. [PMID: 25202324 DOI: 10.3389/fgene.2014.00290] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
111 Yu Q, Yang J, Liu B, Li W, Hu G, Qiu H, Huang L, Xiong H, Yuan X. Combined effects of leukocyte telomere length, p53 polymorphism and human papillomavirus infection on esophageal squamous cell carcinoma in a Han Chinese population. Cancer Epidemiol 2014;38:569-75. [PMID: 25153662 DOI: 10.1016/j.canep.2014.07.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
112 Habbous S, Pang V, Xu W, Amir E, Liu G. Human papillomavirus and host genetic polymorphisms in carcinogenesis: a systematic review and meta-analysis. J Clin Virol 2014;61:220-9. [PMID: 25174543 DOI: 10.1016/j.jcv.2014.07.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
113 Mostaid MS, Ahmed MU, Islam MS, Bin Sayeed MS, Hasnat A. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population. Tumor Biol 2014;35:10309-17. [DOI: 10.1007/s13277-014-2285-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
114 González-herrera L, Rodríguez-morales P, del Refugio González-losa M, Pérez-mendoza G, Canul-canché J, Rosado-lópez I, de Cetina TC. MTHFR/p53 Polymorphisms as Genetic Factors for Cervical Intraepithelial Neoplasia and Cervical Cancer in HPV-infected Mexican Women. Int J Biol Markers 2014;29:142-9. [DOI: 10.5301/jbm.5000070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
115 Ponticelli C, Cucchiari D, Bencini P. Skin cancer in kidney transplant recipients. J Nephrol 2014;27:385-94. [PMID: 24809813 DOI: 10.1007/s40620-014-0098-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
116 Laprano TD, Lemos EH, Cunha LM, Júnior JE, de SousaTeles RA, Rabenhorst SH. Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk. Tumour Biol 2014;35:7435-40. [PMID: 24782034 DOI: 10.1007/s13277-014-1988-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
117 Lu Y, Liu Y, Zeng J, He Y, Peng Q, Deng Y, Wang J, Xie L, Li T, Qin X, Li S. Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysis. Tumour Biol 2014;35:3997-4005. [PMID: 24488627 DOI: 10.1007/s13277-014-1657-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
118 Eskander EF, Abd-Rabou AA, Yahya SM, El Sherbini A, Mohamed MS, Shaker OG. "P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences". Indian J Clin Biochem 2014;29:3-7. [PMID: 24478542 DOI: 10.1007/s12291-013-0317-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
119 Ohno T, Kakinuma S, Kato S, Tsujii H, Shimada Y. Risk of second cancers after radiotherapy for cervical cancer. Expert Review of Anticancer Therapy 2014;6:49-57. [DOI: 10.1586/14737140.6.1.49] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
120 Settheetham-ishida W, Kanjanavirojkul N, Kularbkaew C, Ishida T. Human Papillomavirus Genotypes and the p53 Codon 72 Polymorphism in Cervical Cancer of Northeastern Thailand. Microbiology and Immunology 2005;49:417-21. [DOI: 10.1111/j.1348-0421.2005.tb03745.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
121 Bornstein J, Shavit O. Human Papillomavirus-Associated Diseases in Israel – The Controversy Continues. Vaccine 2013;31:vii-x. [DOI: 10.1016/j.vaccine.2012.05.066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
122 Holloway A, Storey A. A conserved C-terminal sequence of high-risk cutaneous beta-human papillomavirus E6 proteins alters localization and signalling of β1-integrin to promote cell migration. J Gen Virol 2014;95:123-34. [PMID: 24154967 DOI: 10.1099/vir.0.057695-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
123 Svahn MF, Faber MT, Christensen J, Norrild B, Kjaer SK. Prevalence of human papillomavirus in epithelial ovarian cancer tissue. A meta-analysis of observational studies. Acta Obstet Gynecol Scand. 2014;93:6-19. [PMID: 24033121 DOI: 10.1111/aogs.12254] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
124 Cui X, Chen Y, Liu L, Li L, Hu J, Yang L, Liang W, Li F. Heterozygote of PLCE1 rs2274223 increases susceptibility to human papillomavirus infection in patients with esophageal carcinoma among the Kazakh populations. J Med Virol. 2014;86:608-617. [PMID: 24127316 DOI: 10.1002/jmv.23775] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
125 van Monsjou HS, Wreesmann VB, van den Brekel MW, Balm AJ. Head and neck squamous cell carcinoma in young patients. Oral Oncol 2013;49:1097-102. [PMID: 24103389 DOI: 10.1016/j.oraloncology.2013.09.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
126 Zhao L, Zhao X, Wu X, Tang W. Association of p53 Arg72Pro polymorphism with esophageal cancer: a meta-analysis based on 14 case-control studies. Genet Test Mol Biomarkers 2013;17:721-6. [PMID: 23844939 DOI: 10.1089/gtmb.2013.0103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
127 Yang J, Liu B, Li W, Xiong H, Qiu H, Fu Q, Chen B, Hu G, Yuan X. Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC). Cancer Epidemiol 2013;37:629-33. [PMID: 23837945 DOI: 10.1016/j.canep.2013.06.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
128 Dahabreh IJ, Schmid CH, Lau J, Varvarigou V, Murray S, Trikalinos TA. Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer. Am J Epidemiol 2013;177:1317-25. [PMID: 23729685 DOI: 10.1093/aje/kws394] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
129 Xie X, Wang H, Jin H, Ouyang S, Zhou J, Hu J, Xi X, Luo J, Zhang Y, Hu B. Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma. Radiat Oncol 2013;8:117. [PMID: 23663243 DOI: 10.1186/1748-717X-8-117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
130 Alsbeih G, Al-Harbi N, El-Sebaie M, Al-Badawi I. HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia. Infect Agent Cancer 2013;8:15. [PMID: 23642098 DOI: 10.1186/1750-9378-8-15] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
131 Djansugurova LB, Perfilyeva AV, Zhunusova GS, Djantaeva KB, Iksan OA, Khussainova EM. The determination of genetic markers of age-related cancer pathologies in populations from Kazakhstan. Front Genet. 2013;4:70. [PMID: 23675381 DOI: 10.3389/fgene.2013.00070] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
132 Chen F, Ou-yang F, Yang S, Tsai E, Hou M. p53 codon 72 polymorphism in Taiwanese breast cancer patients. The Kaohsiung Journal of Medical Sciences 2013;29:259-64. [DOI: 10.1016/j.kjms.2012.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
133 Pellicciotta I, Yang CP, Venditti CA, Goldberg GL, Shahabi S. Response to microtubule-interacting agents in primary epithelial ovarian cancer cells. Cancer Cell Int 2013;13:33. [PMID: 23574945 DOI: 10.1186/1475-2867-13-33] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
134 Li G, Huang Z, Chen X, Wei Q. Role of human papillomavirus and cell cycle-related variants in squamous cell carcinoma of the oropharynx. J Biomed Res. 2010;24:339-346. [PMID: 23554649 DOI: 10.1016/s1674-8301(10)60047-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
135 Chen X, Jiang J, Shen H, Hu Z. Genetic susceptibility of cervical cancer. J Biomed Res 2011;25:155-64. [PMID: 23554684 DOI: 10.1016/S1674-8301(11)60020-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
136 Chen S, Hsu N, Wu J, Chen C, Chou M, Lee H, Cheng Y. Association of p53 Codon 72 Genotypes and Clinical Outcome in Human Papillomavirus-Infected Lung Cancer Patients. The Annals of Thoracic Surgery 2013;95:1196-203. [DOI: 10.1016/j.athoracsur.2012.12.059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
137 Li L, Wu B, Liu J, Yang L. Vitamin D Receptor Gene Polymorphisms and Type 2 Diabetes: A Meta-analysis. Archives of Medical Research 2013;44:235-41. [DOI: 10.1016/j.arcmed.2013.02.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 5.6] [Reference Citation Analysis]
138 Li Y, Gordon MW, Xu-Monette ZY, Visco C, Tzankov A, Zou D, Qiu L, Montes-Moreno S, Dybkaer K, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huang Q, Ai W, Ponzoni M, Ferreri AJ, Winter JN, Go RS, Piris MA, Møller MB, Wu L, Wang M, Ramos KS, Medeiros LJ, Young KH. Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood 2013;121:4529-40. [PMID: 23515929 DOI: 10.1182/blood-2012-12-471722] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
139 Lopes A. Prognostic factors and biomarkers of penile carcinoma. Expert Opin Med Diagn 2008;2:925-36. [PMID: 23495866 DOI: 10.1517/17530059.2.8.925] [Reference Citation Analysis]
140 Malisic E, Jankovic R, Brotto K, Radulovic S. TP53 codon 72 polymorphism and risk of cervical carcinoma in Serbian women. Arch Gynecol Obstet 2013;288:621-5. [PMID: 23483183 DOI: 10.1007/s00404-013-2783-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
141 Sarkar J, Dominguez E, Li G, Kusewitt DF, Johnson DG. Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibility. Mol Carcinog 2014;53:648-58. [PMID: 23475592 DOI: 10.1002/mc.22019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
142 Lajin B, Alhaj Sakur A, Alachkar A. Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women. Breast Cancer Res Treat 2013;138:611-9. [PMID: 23468244 DOI: 10.1007/s10549-013-2467-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
143 Camelo-santos J, do Prado Barbosa A, de Paula Silveira-lacerda E, Guillo LA. Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia. Biomedicine & Pharmacotherapy 2013;67:103-7. [DOI: 10.1016/j.biopha.2012.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
144 Walter SD, Riddell CA, Rabachini T, Villa LL, Franco EL. Accuracy of p53 codon 72 polymorphism status determined by multiple laboratory methods: a latent class model analysis. PLoS One 2013;8:e56430. [PMID: 23441193 DOI: 10.1371/journal.pone.0056430] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
145 Malisic EJ, Jankovic RN, Jakovljevic KV, Radulovic SS. Association of TP53 codon 72 polymorphism with susceptibility to ovarian carcinomas in Serbian women. European Journal of Obstetrics & Gynecology and Reproductive Biology 2013;166:90-3. [DOI: 10.1016/j.ejogrb.2012.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
146 Doorbar J, Cubie H. Molecular Basis for Advances in Cervical Screening. Molecular Diagnosis 2005;9:129-42. [DOI: 10.1007/bf03260081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
147 Thomas M, Tomaić V, Pim D, Myers MP, Tommasino M, Banks L. Interactions between E6AP and E6 proteins from alpha and beta HPV types. Virology 2013;435:357-62. [PMID: 23206439 DOI: 10.1016/j.virol.2012.11.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
148 Jiang N, Pan J, Wang L, Duan Y. No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer. Tumor Biol 2013;34:587-96. [DOI: 10.1007/s13277-012-0587-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
149 Salehi Z, Hadavi M. Analysis of the codon 72 polymorphism of TP53 and human papillomavirus infection in Iranian patients with prostate cancer. J Med Virol 2012;84:1423-7. [PMID: 22825821 DOI: 10.1002/jmv.23268] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
150 Guerra F, Perrone AM, Kurelac I, Santini D, Ceccarelli C, Cricca M, Zamagni C, De Iaco P, Gasparre G. Mitochondrial DNA mutation in serous ovarian cancer: implications for mitochondria-coded genes in chemoresistance. J Clin Oncol 2012;30:e373-8. [PMID: 23150702 DOI: 10.1200/JCO.2012.43.5933] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
151 Burroni E, Bisanzi S, Sani C, Puliti D, Carozzi F. Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix. J Med Virol 2013;85:83-90. [PMID: 23124863 DOI: 10.1002/jmv.23417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
152 Proestling K, Hebar A, Pruckner N, Marton E, Vinatzer U, Schreiber M. The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk. PLoS One 2012;7:e47325. [PMID: 23071787 DOI: 10.1371/journal.pone.0047325] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
153 Meyrelles ARI, Siqueira JD, Hofer CB, Costa TP, Azevedo AP, Guimarães BV, Seuánez HN, Soares MA, Almeida G, Soares EA, Machado ES. HIV/HPV co-infection during pregnancy in southeastern Brazil: prevalence, HPV types, cytological abnormalities and risk factors. Gynecol Oncol 2013;128:107-12. [PMID: 23063764 DOI: 10.1016/j.ygyno.2012.10.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
154 Soto-Cruz I, Legorreta-Herrera M. Analysis of a p53 mutation associated with cancer susceptibility for biochemistry and genetic laboratory courses. Biochem Mol Biol Educ 2009;37:236-42. [PMID: 21567743 DOI: 10.1002/bmb.20304] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
155 Chattopadhyay K. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet 2011;17:132-44. [PMID: 22345983 DOI: 10.4103/0971-6866.92087] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
156 Szkandera J, Absenger G, Dandachi N, Regitnig P, Lax S, Stotz M, Samonigg H, Renner W, Gerger A. Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer. Mol Genet Genomics 2012;287:755-64. [PMID: 22903472 DOI: 10.1007/s00438-012-0715-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
157 Akbaş H, Yalcin K, Isi H, Tekes S, Atay AE, Akkus Z, Budak T. Role of p53 codon 72 polymorphism in chromosomal aberrations and mitotic index in patients with chronic hepatitis B. Braz J Med Biol Res 2012;45:1011-6. [PMID: 22892830 DOI: 10.1590/s0100-879x2012007500129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
158 Jia S, Tang W, Luo Y. p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis. Hepatol Int 2013;7:669-75. [PMID: 26201800 DOI: 10.1007/s12072-012-9389-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
159 Tessari G, Girolomoni G. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg 2012;38:1622-30. [PMID: 22805312 DOI: 10.1111/j.1524-4725.2012.02520.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
160 Costa KA, Guillo LA. TP53 codon 72 polymorphism in pigmentary phenotypes. J Biosci 2012;37:33-9. [PMID: 22357201 DOI: 10.1007/s12038-012-9183-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
161 Eltahir HA, Elhassan AM, Ibrahim ME. Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer. Mol Med Rep 2012;6:473-6. [PMID: 22692183 DOI: 10.3892/mmr.2012.942] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
162 Altilia S, Santoro A, Malagoli D, Lanzarini C, Ballesteros Álvarez JA, Galazzo G, Porter DC, Crocco P, Rose G, Passarino G, Roninson IB, Franceschi C, Salvioli S. TP53 codon 72 polymorphism affects accumulation of mtDNA damage in human cells. Aging (Albany NY) 2012;4:28-39. [PMID: 22289634 DOI: 10.18632/aging.100425] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
163 Giaimo S, d'Adda di Fagagna F. Is cellular senescence an example of antagonistic pleiotropy? Aging Cell 2012;11:378-83. [PMID: 22329645 DOI: 10.1111/j.1474-9726.2012.00807.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
164 Loeb KR, Asgari MM, Hawes SE, Feng Q, Stern JE, Jiang M, Argenyi ZB, de Villiers EM, Kiviat NB. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas. PLoS One 2012;7:e34422. [PMID: 22545084 DOI: 10.1371/journal.pone.0034422] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
165 Wang Z, Sturgis EM, Guo W, Song X, Zhang F, Xu L, Wei Q, Li G. Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer. PLoS One 2012;7:e35522. [PMID: 22523600 DOI: 10.1371/journal.pone.0035522] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
166 Zheng S, Vuitton L, Sheyhidin I, Vuitton DA, Zhang Y, Lu X. Northwestern China: a place to learn more on oesophageal cancer. Part two: gene alterations and polymorphisms. Eur J Gastroenterol Hepatol. 2011;23:1087-1099. [PMID: 22002005 DOI: 10.1097/meg.0b013e32834a14d9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
167 Ercan C, van Diest PJ, van der Ende B, Hinrichs J, Bult P, Buerger H, van der Wall E, Derksen PW. p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast. Cell Oncol (Dordr) 2012;35:111-8. [PMID: 22354696 DOI: 10.1007/s13402-012-0071-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
168 Lin HY, Huang CH, Yu TJ, Wu WJ, Yang MC, Lung FW. p53 codon 72 polymorphism as a progression index for bladder cancer. Oncol Rep 2012;27:1193-9. [PMID: 22200788 DOI: 10.3892/or.2011.1610] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
169 Lin HY, Yang MC, Huang CH, Wu WJ, Yu TJ, Lung FW. Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis. Urol Oncol 2013;31:1231-41. [PMID: 22178231 DOI: 10.1016/j.urolonc.2011.11.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
170 Wang Z, Sturgis EM, Zhang Y, Huang Z, Zhou Q, Wei Q, Li G. Combined p53-related genetic variants together with HPV infection increase oral cancer risk. Int J Cancer 2012;131:E251-8. [PMID: 22052649 DOI: 10.1002/ijc.27335] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
171 von Keyserling H, Bergmann T, Schuetz M, Schiller U, Stanke J, Hoffmann C, Schneider A, Lehrach H, Dahl A, Kaufmann AM. Analysis of 4 Single-Nucleotide Polymorphisms in Relation to Cervical Dysplasia and Cancer Development Using a High-Throughput Ligation-Detection Reaction Procedure. Int J Gynecol Cancer 2011;21:1664-71. [DOI: 10.1097/igc.0b013e31822b6299] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
172 Koh WP, Van Den Berg D, Jin A, Wang R, Yuan JM, Yu MC. Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore. Breast Cancer Res Treat 2011;130:1011-9. [PMID: 21833626 DOI: 10.1007/s10549-011-1680-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
173 Taylor ATS, Rogers JC. The ethical implications of genetic testing in the classroom. Biochem Mol Biol Educ 2011;39:253-60. [DOI: 10.1002/bmb.20521] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
174 Rogler A, Rogenhofer M, Borchardt A, Lunz JC, Knoell A, Hofstaedter F, Tannapfel A, Wieland W, Hartmann A, Stoehr R. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype. Pathobiology 2011;78:193-200. [PMID: 21778786 DOI: 10.1159/000326767] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
175 Brunner AH, Grimm C, Polterauer S, Hefler L, Stani J, Heinze G, Horvat R. The Prognostic Role of Human Papillomavirus in Patients With Vaginal Cancer: . International Journal of Gynecological Cancer 2011;21:923-9. [DOI: 10.1097/igc.0b013e31821bc615] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
176 Liu L, Wang K, Zhu ZM, Shao JH. Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis. Arch Med Res 2011;42:60-9. [PMID: 21376265 DOI: 10.1016/j.arcmed.2011.01.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
177 Barbisan G, Contreras A, Pérez LO, Difranza L, Golijow CD. The effect of TP53 codon 72 and RNASEL codon 462 polymorphisms on the development of cervical cancer in Argentine women. Cancer Genet 2011;204:270-7. [PMID: 21665181 DOI: 10.1016/j.cancergen.2011.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
178 Nunobiki O, Ueda M, Toji E, Yamamoto M, Akashi K, Sato N, Izuma S, Torii K, Tanaka I, Okamoto Y, Noda S. Genetic Polymorphism of Cancer Susceptibility Genes and HPV Infection in Cervical Carcinogenesis. Patholog Res Int 2011;2011:364069. [PMID: 21660264 DOI: 10.4061/2011/364069] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
179 Sümbül AT, Akkız H, Bayram S, Bekar A, Akgöllü E, Sandıkçı M. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study. Mol Biol Rep. 2012;39:1639-1647. [PMID: 21607615 DOI: 10.1007/s11033-011-0903-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
180 Karmakar A, Bratton SM, Dervishi E, Ghosh A, Mahmood M, Xu Y, Saeed LM, Mustafa T, Casciano D, Radominska-Pandya A, Biris AS. Ethylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cells. Int J Nanomedicine 2011;6:1045-55. [PMID: 21720516 DOI: 10.2147/IJN.S17684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 0.2] [Reference Citation Analysis]
181 Arron ST, Jennings L, Nindl I, Rosl F, Bouwes Bavinck JN, Seçkin D, Trakatelli M, Murphy GM; Viral Working Group of the International Transplant Skin Cancer Collaborative (ITSCC) & Skin Care in Organ Transplant Patients, Europe (SCOPE). Viral oncogenesis and its role in nonmelanoma skin cancer. Br J Dermatol 2011;164:1201-13. [PMID: 21418174 DOI: 10.1111/j.1365-2133.2011.10322.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
182 Murgel de Castro Santos LE, Trindade Guilhen AC, Alves de Andrade R, Garcia Sumi L, Ward LS. The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer. Urologic Oncology: Seminars and Original Investigations 2011;29:291-4. [DOI: 10.1016/j.urolonc.2009.03.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
183 Jiang DK, Yao L, Wang WZ, Peng B, Ren WH, Yang XM, Yu L. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: A meta-analysis. World J Gastroenterol 2011; 17(9): 1227-1233 [PMID: 21448430 DOI: 10.3748/wjg.v17.i9.1227] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
184 Rogers JC, Taylor AT. Teaching about genetic testing issues in the undergraduate classroom: a case study. J Genet Couns 2011;20:231-40. [PMID: 21373958 DOI: 10.1007/s10897-011-9352-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
185 Ihsan R, Devi TR, Yadav DS, Mishra AK, Sharma J, Zomawia E, Verma Y, Phukan R, Mahanta J, Kataki AC, Kapur S, Saxena S. Investigation on the Role of p53 Codon 72 Polymorphism and Interactions with Tobacco, Betel Quid, and Alcohol in Susceptibility to Cancers in a High-Risk Population from North East India. DNA and Cell Biology 2011;30:163-71. [DOI: 10.1089/dna.2010.1119] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
186 Santi R, Cetica V, Franchi A, Pepi M, Cesinaro AM, Miracco C, Paglierani M, De Giorgi V, Delfino C, Difonzo EM, Pimpinelli N, Bianchi S, Sardi I, Santucci M, Massi D. Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapy. Histopathology 2011;58:455-66. [PMID: 21323968 DOI: 10.1111/j.1365-2559.2011.03770.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
187 de Zwaan SE, Haass NK. Genetics of basal cell carcinoma. Australas J Dermatol 2010;51:81-92; quiz 93-4. [PMID: 20546211 DOI: 10.1111/j.1440-0960.2009.00579.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
188 Caamaño J, Saavedra N, Jaramillo PC, Lanas C, Lanas F, Salazar LA. <i>TP53</i> Codon 72 Polymorphism Is Associated with Coronary Artery Disease in Chilean Subjects. Med Princ Pract 2011;20:171-6. [DOI: 10.1159/000321206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
189 Francisco G, Menezes PR, Eluf-Neto J, Chammas R. Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int J Cancer. 2011;129:920-930. [PMID: 20886596 DOI: 10.1002/ijc.25710] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
190 Pandith AA, Shah ZA, Khan NP, Rasool R, Afroze D, Yousuf A, Wani S, Siddiqi M. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genetics and Cytogenetics 2010;203:263-8. [DOI: 10.1016/j.cancergencyto.2010.08.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
191 Zheng ZM. Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 2010;6:730-55. [PMID: 21152115 DOI: 10.7150/ijbs.6.730] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 4.8] [Reference Citation Analysis]
192 Jha P, Jha P, Pathak P, Chosdol K, Suri V, Sharma MC, Kumar G, Singh M, Mahapatra AK, Sarkar C. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3. Exp Mol Pathol 2011;90:167-72. [PMID: 21115003 DOI: 10.1016/j.yexmp.2010.11.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
193 Chung WH, Dao RL, Chen LK, Hung SI. The role of genetic variants in human longevity. Ageing Res Rev 2010;9 Suppl 1:S67-78. [PMID: 20708717 DOI: 10.1016/j.arr.2010.08.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
194 Shi J, Ren Z, Jiao B, Xiao R, Yun H, Chen B, Zhao W, Zhu Q, Chen Z, Chen S. Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia. Int J Cancer 2011;128:233-8. [DOI: 10.1002/ijc.25318] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
195 Ueda M, Toji E, Nunobiki O, Sato N, Izuma S, Torii K, Okamoto Y, Noda S. Germline polymorphisms of glutathione-S-transferase GSTM1, GSTT1 and p53 codon 72 in cervical carcinogenesis. Hum Cell 2010;23:119-25. [PMID: 21166882 DOI: 10.1111/j.1749-0774.2010.00089.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
196 Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2:a001008. [PMID: 20182602 DOI: 10.1101/cshperspect.a001008] [Cited by in Crossref: 847] [Cited by in F6Publishing: 944] [Article Influence: 70.6] [Reference Citation Analysis]
197 Robles AI, Harris CC. Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb Perspect Biol. 2010;2:a001016. [PMID: 20300207 DOI: 10.1101/cshperspect.a001016] [Cited by in Crossref: 155] [Cited by in F6Publishing: 182] [Article Influence: 12.9] [Reference Citation Analysis]
198 Kitkumthorn N, Yanatatsaneejit P, Rabalert J, Dhammawipark C, Mutirangura A. Association of P53 codon 72 polymorphism and ameloblastoma: P53 codon 72 polymorphism in ameloblastoma. Oral Diseases 2010;16:631-5. [DOI: 10.1111/j.1601-0825.2010.01664.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
199 Jiang P, Liu J, Li W, Zeng X, Tang J. Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women. Acta Biochim Biophys Sin (Shanghai) 2010;42:671-6. [PMID: 20732856 DOI: 10.1093/abbs/gmq069] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
200 Vaji S, Salehi Z, Aminian K. Association of p53 codon 72 genetic polymorphism with the risk of ulcerative colitis in northern Iran. Int J Colorectal Dis 2011;26:235-8. [PMID: 20669023 DOI: 10.1007/s00384-010-1021-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
201 Piña-sánchez P, Hernández-hernández DM, Taja-chayeb L, Cerda-flores RM, González-herrera AL, Rodea-avila C, Apresa-garcía T, Ostrosky-wegman P, Vázquez-ortíz G, Mendoza-lorenzo P, Dueñas-gonzález A, Salcedo M. Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer. Med Oncol 2011;28:1507-13. [DOI: 10.1007/s12032-010-9599-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
202 Pim D, Banks L. Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses. APMIS. 2010;118:471-493. [PMID: 20553529 DOI: 10.1111/j.1600-0463.2010.02618.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 7.8] [Reference Citation Analysis]
203 Moodley D, Mody GM, Chuturgoon AA. Functional analysis of the p53 codon 72 polymorphism in black South Africans with rheumatoid arthritis—a pilot study. Clin Rheumatol 2010;29:1099-105. [DOI: 10.1007/s10067-010-1505-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
204 Ferreira da Silva I, Koifman RJ, Quinto Santos Souza C, Ferreira de Almeida Neto O, Koifman S. TP53 Genetic Polymorphisms and Environmental Risk Factors Associated with Cervical Carcinogenesis in A Cohort of Brazilian Women with Cervical Lesions. Journal of Toxicology and Environmental Health, Part A 2010;73:888-900. [DOI: 10.1080/15287391003744823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
205 Rabachini T, Trottier H, Franco EL, Villa LL. Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies. BMC Genet 2010;11:44. [PMID: 20504317 DOI: 10.1186/1471-2156-11-44] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
206 Saini R, Tang TH, Zain RB, Cheong SC, Musa KI, Saini D, Ismail AR, Abraham MT, Mustafa WM, Santhanam J. Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia. J Cancer Res Clin Oncol 2011;137:311-20. [PMID: 20419384 DOI: 10.1007/s00432-010-0886-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
207 Tang NP, Wu YM, Wang B, Ma J. Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer. Eur J Surg Oncol. 2010;36:431-438. [PMID: 20363586 DOI: 10.1016/j.ejso.2010.03.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
208 Thomas L, Kluwe L, Chuzhanova N, Mautner V, Upadhyaya M. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden. Neurogenetics 2010;11:391-400. [PMID: 20358387 DOI: 10.1007/s10048-010-0240-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
209 Zhuo XL, Li Q, Zhou Y, Cai L, Xiang ZL, Yuan W, Zhang XY. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility. Arch Med Res 2009;40:625-34. [PMID: 20082880 DOI: 10.1016/j.arcmed.2009.09.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
210 Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, Liu S, Liu Z, Shi H, Shen H, Hu Z. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer 2011;128:412-7. [DOI: 10.1002/ijc.25342] [Cited by in Crossref: 134] [Cited by in F6Publishing: 133] [Article Influence: 11.2] [Reference Citation Analysis]
211 Hu X, Zhang Z, Ma D, Huettner PC, Massad LS, Nguyen L, Borecki I, Rader JS. TP53, MDM2, NQO1, and susceptibility to cervical cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:755-761. [PMID: 20200430 DOI: 10.1158/1055-9965.epi-09-0886] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
212 Jiang P, Liu J, Zeng X, Li W, Tang J. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women. Cancer Genetics and Cytogenetics 2010;197:174-8. [DOI: 10.1016/j.cancergencyto.2009.11.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
213 Carr-Wilkinson J, O'Toole K, Wood KM, Challen CC, Baker AG, Board JR, Evans L, Cole M, Cheung NK, Boos J, Köhler G, Leuschner I, Pearson AD, Lunec J, Tweddle DA. High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma. Clin Cancer Res 2010;16:1108-18. [PMID: 20145180 DOI: 10.1158/1078-0432.CCR-09-1865] [Cited by in Crossref: 104] [Cited by in F6Publishing: 102] [Article Influence: 8.7] [Reference Citation Analysis]
214 Ye F, Zhang J, Cheng Q, Shen J, Chen H. p53 Codon 72 polymorphism is associated with occurrence of cervical carcinoma in the Chinese population. Cancer Letters 2010;287:117-21. [DOI: 10.1016/j.canlet.2009.06.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
215 Agodi A, Barchitta M, Cipresso R, Marzagalli R, La Rosa N, Caruso M, Castiglione MG, Travali S. Distribution of p53, GST, and MTHFR Polymorphisms and Risk of Cervical Intraepithelial Lesions in Sicily: . International Journal of Gynecological Cancer 2010;20:141-6. [DOI: 10.1111/igc.0b013e3181c20842] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
216 Campo MS. Papillomavirus and disease in humans and animals. Vet Comp Oncol 2003;1:3-14. [PMID: 19379325 DOI: 10.1046/j.1476-5829.2003.00001.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
217 Godai TI, Suda T, Sugano N, Tsuchida K, Shiozawa M, Sekiguchi H, Sekiyama A, Yoshihara M, Matsukuma S, Sakuma Y, Tsuchiya E, Kameda Y, Akaike M, Miyagi Y. Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy. BMC Cancer 2009;9:420. [PMID: 19954513 DOI: 10.1186/1471-2407-9-420] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
218 Pandima Devi K, Sivamaruthi B, Kiruthiga P, Karutha Pandian S. Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits. Hum Exp Toxicol 2010;29:451-8. [DOI: 10.1177/0960327109354938] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
219 Menczer J, Barchana M, Chetrit A, Liphshitz I, Sadetzki S. Incidence Rates of Cervical Carcinoma Among First- and Second-Generation Women of North African Origin in Israel. Int J Gynecol Cancer 2009;19:1606-9. [DOI: 10.1111/igc.0b013e3181a84035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
220 Contu SS, Agnes G, Damin AP, Contu PC, Rosito MA, Alexandre CO, Damin DC. Lack of correlation between p53 codon 72 polymorphism and anal cancer risk. World J Gastroenterol 2009; 15(36): 4566-4570 [PMID: 19777616 DOI: 10.3748/wjg.15.4566] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
221 El khair MM, Ennaji MM, El kebbaj R, Mhand RA, Attaleb M, El Mzibri M. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women. Med Oncol 2010;27:861-6. [DOI: 10.1007/s12032-009-9297-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
222 Zhuo W, Zhang Y, Xiang Z, Cai L, Chen Z. Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls. J Exp Clin Cancer Res 2009;28:115. [PMID: 19682377 DOI: 10.1186/1756-9966-28-115] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
223 Hrstka R, Coates PJ, Vojtesek B. Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment. J Cell Mol Med. 2009;13:440-453. [PMID: 19379143 DOI: 10.1111/j.1582-4934.2008.00634.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
224 Zhou X, Han S, Wang S, Chen X, Dong J, Shi X, Xia Y, Wang X, Hu Z, Shen H. Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: A case-control analysis. Gynecologic Oncology 2009;114:327-31. [DOI: 10.1016/j.ygyno.2009.05.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
225 Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das B, Del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws AL, Helland A, Herrington CS, Hildesheim A, Humbey O, Jee SH, Kim JW, Madeleine MM, Menczer J, Ngan HY, Nishikawa A, Niwa Y, Pegoraro R, Pillai M, Ranzani G, Rezza G, Rosenthal AN, Roychoudhury S, Saranath D, Schmitt VM, Sengupta S, Settheetham-ishida W, Shirasawa H, Snijders PJ, Stoler MH, Suárez-rincón AE, Szarka K, Tachezy R, Ueda M, van der Zee AG, von Knebel Doeberitz M, Wu M, Yamashita T, Zehbe I, Blettner M. TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. The Lancet Oncology 2009;10:772-84. [DOI: 10.1016/s1470-2045(09)70187-1] [Cited by in Crossref: 103] [Cited by in F6Publishing: 103] [Article Influence: 7.9] [Reference Citation Analysis]
226 Zhang Z, Wang M, Wu D, Wang M, Tong N, Tian Y, Zhang Z. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies. Breast Cancer Res Treat 2010;120:509-17. [PMID: 19629678 DOI: 10.1007/s10549-009-0480-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
227 Koshiol J, Hildesheim A, Gonzalez P, Bratti MC, Porras C, Schiffman M, Herrero R, Rodriguez AC, Wacholder S, Yeager M, Chanock SJ, Burk RD, Wang SS. Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited. Cancer Epidemiol Biomarkers Prev 2009;18:1631-7. [PMID: 19423538 DOI: 10.1158/1055-9965.EPI-08-0830] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
228 Pietsch EC, Murphy ME. Low risk HPV-E6 traps p53 in the cytoplasm and induces p53-dependent apoptosis. Cancer Biol Ther 2008;7:1916-8. [PMID: 19158479 DOI: 10.4161/cbt.7.12.7169] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
229 Zhang J, Zhuo WL, Zheng Y, Zhang YS. Polymorphisms of TP53 codon 72 with prostate carcinoma risk: a meta-analysis. Med Oncol 2010;27:540-6. [PMID: 19499352 DOI: 10.1007/s12032-009-9245-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
230 Zhuo XL, Cai L, Xiang ZL, Zhuo WL, Wang Y, Zhang XY. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis. Arch Med Res 2009;40:299-305. [PMID: 19608020 DOI: 10.1016/j.arcmed.2009.03.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
231 Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, Koong A, Pourmand N, Le QT. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2009;74:553-61. [PMID: 19427557 DOI: 10.1016/j.ijrobp.2009.02.015] [Cited by in Crossref: 164] [Cited by in F6Publishing: 156] [Article Influence: 12.6] [Reference Citation Analysis]
232 Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer. 2009;9:95-107. [PMID: 19165225 DOI: 10.1038/nrc2584] [Cited by in Crossref: 427] [Cited by in F6Publishing: 412] [Article Influence: 32.8] [Reference Citation Analysis]
233 Ueda M, Toji E, Nunobiki O, Izuma S, Okamoto Y, Torii K, Noda S. Germline polymorphism of cancer susceptibility genes in gynecologic cancer. Hum Cell 2008;21:95-104. [PMID: 19067761 DOI: 10.1111/j.1749-0774.2008.00058.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
234 Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U, Scott RJ. Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer. Gynecol Oncol 2009;113:109-14. [PMID: 19193430 DOI: 10.1016/j.ygyno.2008.12.036] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
235 Anschau F, Schmitt VM, Lambert APF, Gonçalves MAG, Machado DC. Transition of cervical carcinoma in situ to invasive cancer: Role of p16INK4a expression in progression and in recurrence. Experimental and Molecular Pathology 2009;86:46-50. [DOI: 10.1016/j.yexmp.2008.11.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
236 Chen X, Sturgis EM, Etzel CJ, Wei Q, Li G. p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers. Cancer 2008;113:3307-14. [PMID: 18988287 DOI: 10.1002/cncr.23976] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
237 Kim N, Cho SI, Lee HS, Park JH, Kim JH, Kim JS, Jung HC, Song IS. The discrepancy between genetic polymorphism of p53 codon 72 and the expression of p53 protein in Helicobacter pylori-associated gastric cancer in Korea. Dig Dis Sci. 2010;55:101-110. [PMID: 19184427 DOI: 10.1007/s10620-008-0688-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
238 Zemleduch T, Lianeri M, Rydzanicz M, Gajecka M, Szyfter K, Jagodziński PP. Contribution of polymorphism in codon 72 of TP53 gene to laryngeal cancer in Polish patients. Oral Oncol 2009;45:683-6. [PMID: 19091625 DOI: 10.1016/j.oraloncology.2008.10.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
239 Chen RH, Chang CT, Wang TY, Huang WL, Tsai CH, Tsai FJ. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases. J Clin Lab Anal 2008;22:321-6. [PMID: 18803266 DOI: 10.1002/jcla.20249] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
240 Chen AC, Mcmillan NAJ, Antonsson A. Human papillomavirus type spectrum in normal skin of individuals with or without a history of frequent sun exposure. Journal of General Virology 2008;89:2891-7. [DOI: 10.1099/vir.0.2008/003665-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
241 Zheng X, Yang A, Pan X, Zheng L, Wang X, Zhou Q, Li X, Yan L, Zhang B, Li H, Jiang J. Ethnicity determines association of p53Arg72Pro alleles with cervical cancer in China. European Journal of Cancer Prevention 2008;17:460-6. [DOI: 10.1097/cej.0b013e3282f75f3e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
242 Zhang Z, Fu G, Wang M, Tong N, Wang S, Zhang Z. P53 codon 72 polymorphism and ovarian cancer risk: a meta-analysis. Journal of Nanjing Medical University 2008;22:279-85. [DOI: 10.1016/s1007-4376(08)60080-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
243 Tornesello ML, Duraturo ML, Guida V, Losito S, Botti G, Pilotti S, Stefanon B, Palo GD, Buonaguro L, Buonaguro FM. Analysis of TP53 codon 72 polymorphism in HPV-positive and HPV-negative penile carcinoma. Cancer Letters 2008;269:159-64. [DOI: 10.1016/j.canlet.2008.04.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
244 Chen X, Sturgis EM, El-Naggar AK, Wei Q, Li G. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis 2008;29:2120-5. [PMID: 18701437 DOI: 10.1093/carcin/bgn191] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
245 Walter SD, Franco EL. Use of latent class models to accommodate inter-laboratory variation in assessing genetic polymorphisms associated with disease risk. BMC Genet 2008;9:51. [PMID: 18691419 DOI: 10.1186/1471-2156-9-51] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
246 Xu Y, Yao L, Zhao A, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Lu Y, Xie Y. Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status. Int J Cancer 2008;122:2761-6. [PMID: 18348141 DOI: 10.1002/ijc.23454] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
247 Israni AK, Li N, Cizman BB, Snyder J, Abrams J, Joffe M, Rebbeck T, Feldman HI. Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation. Am J Kidney Dis 2008;52:331-9. [PMID: 18640487 DOI: 10.1053/j.ajkd.2008.05.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
248 Zhang X, Zhang H, Zhang P, Lu X, Sun H. Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology 2008;139:237-44. [DOI: 10.1016/j.ejogrb.2007.12.021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
249 Kibel AS, Jin CH, Klim A, Luly J, A. Roehl K, Wu WS, Suarez BK. Association between polymorphisms in cell cycle genes and advanced prostate carcinoma. Prostate 2008;68:1179-86. [DOI: 10.1002/pros.20784] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
250 Lyman RC, Wilson ML, Herrington CS. Cell-Cycle Control Protein Expression Is Disrupted in Anogenital Condylomata Infected With Low-Risk Human Papillomavirus Types. Journal of Lower Genital Tract Disease 2008;12:224-31. [DOI: 10.1097/lgt.0b013e318166eff2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
251 Menczer J, Ben-shem E, Golan A, Levy T. Risk Factor Proportions in Israeli Patients With Cervical Intraepithelial Neoplasia 3 and Invasive Squamous Cell Carcinoma. Journal of Lower Genital Tract Disease 2008;12:220-3. [DOI: 10.1097/lgt.0b013e3181652de2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
252 Mammano E, Belluco C, Bonafé M, Olivieri F, Mugianesi E, Barbi C, Mishto M, Cosci M, Franceschi C, Lise M, Nitti D. Association of p53 polymorphisms and colorectal cancer: modulation of risk and progression. Eur J Surg Oncol 2009;35:415-9. [PMID: 18468835 DOI: 10.1016/j.ejso.2008.03.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
253 Thomas M, Dasgupta J, Zhang Y, Chen X, Banks L. Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates. Virology 2008;376:371-8. [PMID: 18452965 DOI: 10.1016/j.virol.2008.03.021] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
254 Shao Y, Tan W, Zhang S. P53 gene codon 72 polymorphism and risk of esophageal squamous cell carcinoma: a case/control study in a Chinese population. Dis Esophagus 2008;21:139-43. [PMID: 18269649 DOI: 10.1111/j.1442-2050.2007.00746.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
255 Yang W, Zhang Y, Tian X, Ning T, Ke Y. p53 Codon 72 polymorphism and the risk of esophageal squamous cell carcinoma. Mol Carcinog 2008;47:100-4. [PMID: 17918207 DOI: 10.1002/mc.20368] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
256 Huang ZH, Hua D, Li LH, Zhu JD. Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy. J Cancer Res Clin Oncol. 2008;134:1129-1134. [PMID: 18357466 DOI: 10.1007/s00432-008-0380-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
257 Boldrini L, Gisfredi S, Ursino S, Lucchi M, Greco G, Mussi A, Donati V, Fontanini G. Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) prognosis. Cancer Invest 2008;26:168-72. [PMID: 18259947 DOI: 10.1080/07357900701788023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
258 Urman CO, Gottlieb AB. New viral vaccines for dermatologic disease. Journal of the American Academy of Dermatology 2008;58:361-70. [DOI: 10.1016/j.jaad.2007.07.051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
259 Martin CM, Kehoe L, Spillane CO, O'Leary JJ. Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers. Mol Diagn Ther 2007;11:277-90. [PMID: 17963416 DOI: 10.1007/BF03256249] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
260 Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, Silva A, Amorim J, Lopes JM, Reis RM. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Cancer Genet Cytogenet 2008;180:14-9. [PMID: 18068527 DOI: 10.1016/j.cancergencyto.2007.08.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
261 Lum SS, Chua HW, Li H, Li WF, Rao N, Wei J, Shao Z, Sabapathy K. MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population. Carcinogenesis. 2008;29:754-761. [PMID: 18281248 DOI: 10.1093/carcin/bgn024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
262 Ji X, Neumann AS, Sturgis EM, Adler-Storthz K, Dahlstrom KR, Schiller JT, Wei Q, Li G. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis 2008;29:875-9. [PMID: 18258602 DOI: 10.1093/carcin/bgn039] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
263 Zhang J, Ye F, Cheng Q, Shen J, Chen H. No association of the POLI Thr706Ala polymorphism with the risk of cervical carcinoma. Eur J Surg Oncol 2008;34:916-20. [PMID: 18194848 DOI: 10.1016/j.ejso.2007.11.008] [Reference Citation Analysis]
264 Oliveira S, Sousa H, Santos A, Pinto D, Pinto-correia A, Fontoura D, Moutinho J, Medeiros R. The p53 R72P polymorphism does not influence cervical cancer development in a portuguese population: A study in exfoliated cervical cells. J Med Virol 2008;80:424-9. [DOI: 10.1002/jmv.21103] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
265 Reinbold M, Luo JL, Nedelko T, Jerchow B, Murphy ME, Whibley C, Wei Q, Hollstein M. Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72. Oncogene 2008;27:2788-94. [PMID: 17998932 DOI: 10.1038/sj.onc.1210932] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
266 Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML, Wu XT. P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer. 2007;121:1481-1486. [PMID: 17546594 DOI: 10.1002/ijc.22833] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 6.0] [Reference Citation Analysis]
267 Idbaih A, Boisselier B, Marie Y, El Hallani S, Sanson M, Crinière E, Rodero M, Carpentier C, Paris S, Laigle-Donadey F, Ducray F, Hoang-Xuan K, Delattre JY. TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors. Cancer Genet Cytogenet 2007;177:103-7. [PMID: 17854663 DOI: 10.1016/j.cancergencyto.2007.06.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
268 Hadhri-guiga B, Toumi N, Khabir A, Sellami-boudawara T, Ghorbel A, Daoud J, Frikha M, Gargouri A, Mokdad-gargouri R. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia. Cancer Genetics and Cytogenetics 2007;178:89-93. [DOI: 10.1016/j.cancergencyto.2007.05.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
269 Holtkamp N, Atallah I, Okuducu AF, Mucha J, Hartmann C, Mautner VF, Friedrich RE, Mawrin C, von Deimling A. MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors. Neoplasia 2007;9:671-7. [PMID: 17786186 DOI: 10.1593/neo.07304] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
270 So S, Adachi N, Koyama H. Absence of p53 enhances growth defects and etoposide sensitivity of human cells lacking the Bloom syndrome helicase BLM. DNA Cell Biol 2007;26:517-25. [PMID: 17630856 DOI: 10.1089/dna.2007.0578] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
271 Torrente MC, Ojeda JM. Exploring the relation between human papilloma virus and larynx cancer. Acta Otolaryngol 2007;127:900-6. [PMID: 17712666 DOI: 10.1080/00016480601110238] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
272 Giuliani L, Jaxmar T, Casadio C, Gariglio M, Manna A, D’antonio D, Syrjanen K, Favalli C, Ciotti M. Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer 2007;57:273-81. [DOI: 10.1016/j.lungcan.2007.02.019] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
273 Singh V, Rastogi N, Mathur N, Singh K, Singh MP. Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women. Ann Epidemiol 2008;18:48-57. [PMID: 17719241 DOI: 10.1016/j.annepidem.2007.06.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
274 Govan VA, Loubser S, Saleh D, Hoffman M, Williamson AL. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency. Int J Immunogenet 2007;34:213-7. [PMID: 17504512 DOI: 10.1111/j.1744-313X.2007.00678.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
275 Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci. 2007;98:1505-1511. [PMID: 17645777 DOI: 10.1111/j.1349-7006.2007.00546.x] [Cited by in Crossref: 257] [Cited by in F6Publishing: 245] [Article Influence: 17.1] [Reference Citation Analysis]
276 Perrone F, Mariani L, Pastore E, Orsenigo M, Suardi S, Marcomini B, DaRiva L, Licitra L, Carbone A, Pierotti MA, Pilotti S. p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx. Cancer 2007;109:2461-5. [PMID: 17492690 DOI: 10.1002/cncr.22702] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
277 Kashima T, Makino K, Soemantri A, Ishida T. TP53 codon 72 polymorphism in 12 populations of insular Southeast Asia and Oceania. J Hum Genet 2007;52:694-7. [DOI: 10.1007/s10038-007-0168-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
278 Vietri MT, Riegler G, Ursillo A, Caserta L, Cioffi M, Molinari AM. p53 codon 72 polymorphism in patients affected with ulcerative colitis. J Gastroenterol. 2007;42:456-460. [PMID: 17671760 DOI: 10.1007/s00535-007-2026-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
279 Park MS, Chang YS, Shin JH, Kim DJ, Chung KY, Shin DH, Moon JW, Kang SM, Hahn CH, Kim YS, Chang J, Kim SK, Kim SK. The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients. Yonsei Med J 2007;48:69-77. [PMID: 17326248 DOI: 10.3349/ymj.2007.48.1.69] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
280 Madkan VK, Cook-Norris RH, Steadman MC, Arora A, Mendoza N, Tyring SK. The oncogenic potential of human papillomaviruses: a review on the role of host genetics and environmental cofactors. Br J Dermatol 2007;157:228-41. [PMID: 17553059 DOI: 10.1111/j.1365-2133.2007.07961.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
281 Zang Y, Zhao S, Doll MA, States JC, Hein DW. Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2. Pharmacogenet Genomics 2007;17:37-45. [PMID: 17264801 DOI: 10.1097/01.fpc.0000236325.73186.2c] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
282 Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007;26:2157-65. [PMID: 17401424 DOI: 10.1038/sj.onc.1210302] [Cited by in Crossref: 563] [Cited by in F6Publishing: 565] [Article Influence: 37.5] [Reference Citation Analysis]
283 Menendez D, Inga A, Jordan JJ, Resnick MA. Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson. Oncogene 2007;26:2191-201. [PMID: 17401428 DOI: 10.1038/sj.onc.1210277] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
284 Perfumo C, Bonelli L, Menichini P, Inga A, Gismondi V, Ciferri E, Percivale P, Bianchi Scarrà G, Nasti S, Fronza G, Varesco L. Increased Risk of Colorectal Adenomas in Italian Subjects Carrying the <i>p53</i> PIN3 A2-Pro72 Haplotype. Digestion 2007;74:228-35. [DOI: 10.1159/000100966] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
285 Vietri MT, Molinari AM, Iannella I, Cioffi M, Bontempo P, Ardovino M, Scaffa C, Colacurci N, Cobellis L. Arg72Pro p53 polymorphism in Italian women: no association with endometriosis. Fertil Steril 2007;88:1468-9. [PMID: 17412337 DOI: 10.1016/j.fertnstert.2006.12.049] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
286 Laing ME, Kay E, Conlon P, Murphy GM. Genetic factors associated with skin cancer in renal transplant patients. Photoderm Photoimm Photomed 2007;23:62-7. [DOI: 10.1111/j.1600-0781.2007.00282.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
287 Khadang B, Fattahi MJ, Talei A, Dehaghani AS, Ghaderi A. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women. Cancer Genet Cytogenet 2007;173:38-42. [PMID: 17284368 DOI: 10.1016/j.cancergencyto.2006.09.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
288 Shaw A. Exploring the perioptome: the role of genomics in thoracic surgery and anaesthesia. Curr Opin Anaesthesiol 2007;20:32-6. [PMID: 17211164 DOI: 10.1097/ACO.0b013e32801271e4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
289 Kuroda Y, Nakao H, Ikemura K, Katoh T. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. Oral Oncol 2007;43:1043-8. [PMID: 17306604 DOI: 10.1016/j.oraloncology.2006.12.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
290 Stefanaki I, Stratigos A, Dimisianos G, Nikolaou V, Papadopoulos O, Polydorou D, Gogas H, Tsoutsos D, Panagiotou P, Kanavakis E, Antoniou C, Katsambas A. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants. Br J Dermatol 2007;156:357-62. [DOI: 10.1111/j.1365-2133.2006.07645.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 265] [Article Influence: 1.7] [Reference Citation Analysis]
291 Sousa H, Santos AM, Catarino R, Pinto D, Vasconcelos A, Lopes C, Breda E, Medeiros R. Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development. Eur J Cancer Prev. 2006;15:362-366. [PMID: 16835507 DOI: 10.1097/00008469-200608000-00010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
292 Krüger S, Engel C, Bier A, Silber AS, Görgens H, Mangold E, Pagenstecher C, Holinski-Feder E, von Knebel Doeberitz M, Royer-Pokora B, Dechant S, Pox C, Rahner N, Müller A, Schackert HK; German HNPCC Consortium. The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1. Cancer Lett 2007;252:55-64. [PMID: 17224235 DOI: 10.1016/j.canlet.2006.12.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
293 Bendesky A, Rosales A, Salazar AM, Sordo M, Peniche J, Ostrosky-Wegman P. p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer. Mutat Res 2007;619:38-44. [PMID: 17403527 DOI: 10.1016/j.mrfmmm.2007.01.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
294 Nadji SA, Mahmoodi M, Ziaee AA, Naghshvar F, Torabizadeh J, Yahyapour Y, Nategh R, Mokhtari-Azad T. An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran. Lung Cancer 2007;56:145-51. [PMID: 17208332 DOI: 10.1016/j.lungcan.2006.12.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
295 Malmer BS, Feychting M, Lönn S, Lindström S, Grönberg H, Ahlbom A, Schwartzbaum J, Auvinen A, Collatz-Christensen H, Johansen C, Kiuru A, Mudie N, Salminen T, Schoemaker MJ, Swerdlow AJ, Henriksson R. Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol 2007;82:229-37. [PMID: 17151932 DOI: 10.1007/s11060-006-9275-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
296 Phang BH, Sabapathy K. The codon 72 polymorphism-specific effects of human p53 are absent in mouse cells: implications on generation of mouse models. Oncogene 2007;26:2964-74. [DOI: 10.1038/sj.onc.1210112] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
297 Mitra S, Banerjee S, Misra C, Singh RK, Roy A, Sengupta A, Panda CK, Roychoudhury S. Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population. J Clin Pathol. 2007;60:1040-1047. [PMID: 17079356 DOI: 10.1136/jcp.2005.034835] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
298 Koushik A, Tranah GJ, Ma J, Stampfer MJ, Sesso HD, Fuchs CS, Giovannucci EL, Hunter DJ. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer. 2006;119:1863-1868. [PMID: 16721787 DOI: 10.1002/ijc.22057] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
299 Lu X, Feki A. Phenotypic features with p53 alterations related to human papillomavirus and prognostic evaluation in cervical cancer. Int J Gynecol Cancer 2006;16:708-17. [PMID: 16681751 DOI: 10.1111/j.1525-1438.2006.00591.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
300 Min-min H, Ming-rong X, Ze-yi C, Kai-xuan Y, Zhi-lin S. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions. Int J Gynecol Cancer 2006;16:2004-8. [DOI: 10.1111/j.1525-1438.2006.00733.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
301 Ahmed FE. Gene-gene, gene-environment & multiple interactions in colorectal cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2006;24:1-101. [PMID: 16690537 DOI: 10.1080/10590500600614295] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
302 Esser AC, Pittelkow MR, Randle HW. Human papillomavirus isolated from transplant-associated porokeratoses of mibelli responsive to topical 5% imiquimod cream. Dermatol Surg 2006;32:858-61. [PMID: 16792657 DOI: 10.1111/j.1524-4725.2006.32176.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
303 Hsieh YY, Lin CS. P53 codon 11, 72, and 248 gene polymorphisms in endometriosis. Int J Biol Sci 2006;2:188-93. [PMID: 16896365 DOI: 10.7150/ijbs.2.188] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
304 Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006;110:525-541. [PMID: 16597322 DOI: 10.1042/cs20050369] [Cited by in Crossref: 584] [Cited by in F6Publishing: 545] [Article Influence: 36.5] [Reference Citation Analysis]
305 Chung WC, Lee KM, Lee BI, Chun JS, Lee SY, Chang UI, Park SH, Yang JM, Choi KY, Chung IS. P53 genetic polymorphism of gastric cancer in Korea. Korean J Intern Med 2006;21:28-32. [PMID: 16646561 DOI: 10.3904/kjim.2006.21.1.28] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
306 Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky Y, Jackman A, Tommasino M, Zehbe I, Sherman L. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology 2006;350:216-27. [DOI: 10.1016/j.virol.2006.01.038] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 3.4] [Reference Citation Analysis]
307 Kang YH, Lee K, Ryu CJ, Lee H, Lim J, Park SN, Paik S, Yoon D. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells. Cancer Letters 2006;237:33-44. [DOI: 10.1016/j.canlet.2005.05.043] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
308 Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ. Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53. Int J Cancer 2006;118:2479-84. [PMID: 16353134 DOI: 10.1002/ijc.21661] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
309 Morari EC, Lima AB, Bufalo NE, Leite JL, Granja F, Ward LS. Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients. J Cancer Res Clin Oncol 2006;132:521-8. [PMID: 16788846 DOI: 10.1007/s00432-006-0099-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
310 Kouidou S, Malousi A, Maglaveras N. Methylation and repeats in silent and nonsense mutations of p53. Mutat Res 2006;599:167-77. [PMID: 16620878 DOI: 10.1016/j.mrfmmm.2006.03.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
311 Murphy ME. Polymorphic variants in the p53 pathway. Cell Death Differ 2006;13:916-20. [DOI: 10.1038/sj.cdd.4401907] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 3.9] [Reference Citation Analysis]
312 Santos AM, Sousa H, Pinto D, Portela C, Pereira D, Catarino R, Duarte I, Lopes C, Medeiros R. Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer. Eur J Cancer 2006;42:958-63. [PMID: 16542834 DOI: 10.1016/j.ejca.2006.01.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
313 Pietsch EC, Humbey O, Murphy ME. Polymorphisms in the p53 pathway. Oncogene 2006;25:1602-11. [DOI: 10.1038/sj.onc.1209367] [Cited by in Crossref: 151] [Cited by in F6Publishing: 141] [Article Influence: 9.4] [Reference Citation Analysis]
314 Pérez LO, Abba MC, Dulout FN, Golijow CD. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol 2006; 12(9): 1426-1429 [PMID: 16552814 DOI: 10.3748/wjg.v12.i9.1426] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
315 Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer 2006;52:9-14. [PMID: 16499995 DOI: 10.1016/j.lungcan.2005.12.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
316 Gudleviciene Z, Didziapetriene J, Ramael M, Uleckiene S, Valuckas KP. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients. Gynecol Oncol 2006;102:530-3. [PMID: 16488468 DOI: 10.1016/j.ygyno.2006.01.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
317 Siddique M, Sabapathy K. Trp53-dependent DNA-repair is affected by the codon 72 polymorphism. Oncogene 2006;25:3489-500. [PMID: 16462765 DOI: 10.1038/sj.onc.1209405] [Cited by in Crossref: 82] [Cited by in F6Publishing: 91] [Article Influence: 5.1] [Reference Citation Analysis]
318 Tsai C, Huang K, Chen H, Zhan B, Lai Y, Lee F, Lin C, Ho Y, Chao Y, Su Y, Jane S, Chen Y, Hsu C, Li P, Hsu H, Suzuki Y, Sugano S, Lin J. Gene expression analysis of human hepatocellular carcinoma by using full-length cDNA library. J Biomed Sci 2006;13:241-9. [DOI: 10.1007/s11373-005-9062-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
319 Belyavskaya VA, Vardosanidze VK, Smirnova OY, Karakin EI, Savkin IV, Gervas PA, Cherdyntseva NV, Voevoda MI. Genetic status of p53 in stomach cancer: Somatic mutations and polymorphism of codon 72. Bull Exp Biol Med 2006;141:243-6. [DOI: 10.1007/s10517-006-0139-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
320 Puente XS, Velasco G, Gutiérrez-Fernández A, Bertranpetit J, King MC, López-Otín C. Comparative analysis of cancer genes in the human and chimpanzee genomes. BMC Genomics. 2006;7:15. [PMID: 16438707 DOI: 10.1186/1471-2164-7-15] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
321 Monnier-Benoit S, Mauny F, Riethmuller D, Guerrini JS, Căpîlna M, Félix S, Seillès E, Mougin C, Prétet JL. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol Oncol 2006;102:22-31. [PMID: 16427684 DOI: 10.1016/j.ygyno.2005.11.039] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
322 Jain N, Singh V, Hedau S, Kumar S, Daga MK, Dewan R, Murthy NS, Husain SA, Das BC. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 2005;128:3999-4007. [PMID: 16354872 DOI: 10.1378/chest.128.6.3999] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
323 Baay MF, Verhoeven V, Avonts D, Vermorken JB. Risk factors for cervical cancer development: what do women think? Sex Health 2004;1:145-9. [PMID: 16335302 DOI: 10.1071/sh04004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
324 Ueda M, Hung Y, Terai Y, Saito J, Nunobiki O, Noda S, Ueki M. HER-2 codon 655 polymorphism in cervical carcinogenesis. Int J Gynecol Cancer 2006;16:325-8. [DOI: 10.1111/j.1525-1438.2006.00349.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
325 Twu C, Jiang R, Shu C, Lin J. Association of p53 Codon 72 Polymorphism with Risk of Hypopharyngeal Squamous Cell Carcinoma in Taiwan. Journal of the Formosan Medical Association 2006;105:99-104. [DOI: 10.1016/s0929-6646(09)60330-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
326 Ueda M, Terai Y, Kanda K, Kanemura M, Takehara M, Yamaguchi H, Nishiyama K, Yasuda M, Ueki M. Germline polymorphism of p53 codon 72 in gynecological cancer. Gynecologic Oncology 2006;100:173-8. [DOI: 10.1016/j.ygyno.2005.08.015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
327 Damin AP, Frazzon AP, Damin DC, Roehe A, Hermes V, Zettler C, Alexandre CO. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. Cancer Detection and Prevention 2006;30:523-9. [DOI: 10.1016/j.cdp.2006.09.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.0] [Reference Citation Analysis]
328 Santos AM, Sousa H, Portela C, Pereira D, Pinto D, Catarino R, Rodrigues C, Araújo AP, Lopes C, Medeiros R. TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer. Biochem Biophys Res Commun. 2006;340:256-262. [PMID: 16364249 DOI: 10.1016/j.bbrc.2005.11.176] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
329 Lee JM, Shun CT, Wu MT, Chen YY, Yang SY, Hung HI, Chen JS, Hsu HH, Huang PM, Kuo SW, Lee YC. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer. Mutat Res 2006;594:181-8. [PMID: 16318864 DOI: 10.1016/j.mrfmmm.2005.09.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
330 Ma H, Hu Z, Zhai X, Wang S, Wang X, Qin J, Chen W, Jin G, Liu J, Gao J, Wang X, Wei Q, Shen H. Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population. Carcinogenesis 2006;27:766-71. [DOI: 10.1093/carcin/bgi295] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
331 Leiros GJ, Galliano SR, Sember ME, Kahn T, Schwarz E, Eiguchi K. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol 2005;5:15. [PMID: 16307686 DOI: 10.1186/1471-2490-5-15] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
332 Bhattacharya P, Sengupta S. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women. Gynecol Oncol 2005;99:176-82. [PMID: 16054204 DOI: 10.1016/j.ygyno.2005.06.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
333 Zhu Z, Cong W, Liu S, Xian Z, Wu W, Wu M, Gao B, Hou L, Zhu G. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Cancer Letters 2005;229:77-83. [DOI: 10.1016/j.canlet.2005.04.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
334 Lai HS, Lee JC, Lee PH, Wang ST, Chen WJ. Plasma free amino acid profile in cancer patients. Semin Cancer Biol. 2005;15:267-276. [PMID: 15894488 DOI: 10.1016/j.semcancer.2005.04.003] [Cited by in Crossref: 109] [Cited by in F6Publishing: 116] [Article Influence: 6.4] [Reference Citation Analysis]
335 Medeiros R, Prazeres H, Pinto D, Macedo-pinto I, Lacerda M, Lopes C, Cruz E. Characterization of HPV genotype profile in squamous cervical lesions in Portugal, a southern European population at high risk of cervical cancer. European Journal of Cancer Prevention 2005;14:467-71. [DOI: 10.1097/01.cej.0000178079.29533.1e] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
336 Matos A, Moutinho J, Pinto D, Medeiros R. The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population. European Journal of Cancer Prevention 2005;14:485-91. [DOI: 10.1097/01.cej.0000174780.44260.32] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
337 Yamaguchi S, Tsuda H, Takemori M, Nakata S, Nishimura S, Kawamura N, Hanioka K, Inoue T, Nishimura R. Photodynamic Therapy for Cervical Intraepithelial Neoplasia. Oncology 2005;69:110-6. [DOI: 10.1159/000087812] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]
338 Saffari B, Bernstein L, Hong D, Sullivan-halley J, Runnebaum I, Grill H, Jones L, El-naggar A, Press M. Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer 2005;15:952-63. [DOI: 10.1111/j.1525-1438.2005.00159.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
339 Sul J, Yu GP, Lu QY, Lu ML, Setiawan VW, Wang MR, Guo CH, Yu SZ, Mu L, Cai L. P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions. Cancer Lett. 2006;238:210-223. [PMID: 16111803 DOI: 10.1016/j.canlet.2005.07.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
340 Sturm I, Bosanquet AG, Hummel M, Dörken B, Daniel PT. In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis. BMC Cancer 2005;5:105. [PMID: 16109171 DOI: 10.1186/1471-2407-5-105] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
341 Tiersma ES, van der Lee ML, Garssen B, Peters AA, Visser AP, Fleuren GJ, van Leeuwen KM, le Cessie S, Goodkin K. Psychosocial factors and the course of cervical intra-epithelial neoplasia: a prospective study. Gynecol Oncol 2005;97:879-86. [PMID: 15894367 DOI: 10.1016/j.ygyno.2005.03.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
342 Martínez-lucas P, Moreno-cuesta J, García-olmo DC, Sánchez-sánchez F, Escribano-martínez J, del Pozo AC, Lizán-garcía M, García-olmo D. Relationship between the Arg72Pro Polymorphism of p53 and outcome for patients with traumatic brain injury. Intensive Care Med 2005;31:1168-73. [DOI: 10.1007/s00134-005-2715-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
343 Santos AM, Sousa H, Catarino R, Pinto D, Pereira D, Vasconcelos A, Matos A, Lopes C, Medeiros R. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal. Cancer Genet Cytogenet 2005;159:143-7. [PMID: 15899386 DOI: 10.1016/j.cancergencyto.2004.10.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
344 Denschlag D, Bettendorf H, Watermann D, Keck C, Tempfer C, Pietrowski D. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma. Fertility and Sterility 2005;84:162-6. [DOI: 10.1016/j.fertnstert.2005.01.103] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
345 Boukamp P. UV-induced Skin Cancer: Similarities - Variations. Durch UV-Strahlung induzierte Hauttumore: Gemeinsamkeiten - Unterschiede. J Deut Dermatol Gesell 2005;3:493-503. [DOI: 10.1111/j.1610-0387.2005.05037.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
346 Wang XL, Wang J. Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis. World J Surg 2005;29:344-53. [PMID: 15696395 DOI: 10.1007/s00268-004-7819-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
347 Das S, Nama S, Antony S, Somasundaram K. p73 beta-expressing recombinant adenovirus: a potential anticancer agent. Cancer Gene Ther 2005;12:417-26. [PMID: 15678153 DOI: 10.1038/sj.cgt.7700803] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
348 Kalemi TG, Lambropoulos AF, Gueorguiev M, Chrisafi S, Papazisis KT, Kotsis A. The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett 2005;222:57-65. [PMID: 15837541 DOI: 10.1016/j.canlet.2004.11.025] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
349 Chen Z, Terai M, Fu L, Herrero R, DeSalle R, Burk RD. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 2005;79:7014-23. [PMID: 15890941 DOI: 10.1128/JVI.79.11.7014-7023.2005] [Cited by in Crossref: 119] [Cited by in F6Publishing: 112] [Article Influence: 7.0] [Reference Citation Analysis]
350 Jais PH. How frequent is altered gene expression among susceptibility genes to human complex disorders? Genet Med 2005;7:83-96. [PMID: 15714075 DOI: 10.1097/01.gim.0000153665.55420.c3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
351 Joseph J, Wajapeyee N, Somasundaram K. Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate. Int J Cancer 2005;115:11-8. [PMID: 15688418 DOI: 10.1002/ijc.20842] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
352 Pérez-Pérez GI, Bosques-Padilla FJ, Crosatti ML, Tijerina-Menchaca R, Garza-González E. Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scand J Gastroenterol 2005;40:56-60. [PMID: 15841715 DOI: 10.1080/00365520410009456] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
353 Ueda M, Hung YC, Terai Y, Saito J, Nunobiki O, Noda S, Ueki M. Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis. Gynecol Oncol. 2005;96:736-740. [PMID: 15721419 DOI: 10.1016/j.ygyno.2004.11.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
354 Ohayon T, Gershoni-Baruch R, Papa MZ, Distelman Menachem T, Eisenberg Barzilai S, Friedman E. The R72P P53 mutation is associated with familial breast cancer in Jewish women. Br J Cancer 2005;92:1144-8. [PMID: 15756275 DOI: 10.1038/sj.bjc.6602451] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
355 Schneider-Stock R, Boltze C, Peters B, Szibor R, Landt O, Meyer F, Roessner A. Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer. Neoplasia. 2004;6:529-535. [PMID: 15548361 DOI: 10.1593/neo.04178] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
356 Niwa Y, Hirose K, Matsuo K, Tajima K, Ikoma Y, Nakanishi T, Nawa A, Kuzuya K, Tamakoshi A, Hamajima N. Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Cancer Lett 2005;219:183-90. [PMID: 15723718 DOI: 10.1016/j.canlet.2004.10.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
357 Zang Y, Zhao S, Doll MA, States JC, Hein DW. The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation. Pharmacogenetics 2004;14:717-23. [PMID: 15564878 DOI: 10.1097/00008571-200411000-00002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
358 de Moura Gallo CV, Azevedo E Silva Mendonça G, de Moraes E, Olivier M, Hainaut P. TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives. Mutat Res 2005;589:192-207. [PMID: 15878142 DOI: 10.1016/j.mrrev.2005.01.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
359 Sterling JC. Human papillomaviruses and skin cancer. Journal of Clinical Virology 2005;32:67-71. [DOI: 10.1016/j.jcv.2004.11.018] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
360 Mitra S, Misra C, Singh RK, Panda CK, Roychoudhury S. Association of specific genotype and haplotype of p53 gene with cervical cancer in India. J Clin Pathol 2005;58:26-31. [PMID: 15623478 DOI: 10.1136/jcp.2004.019315] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
361 Yim EK, Lee KH, Bae JS, Namkoong SE, Um SJ, Park JS. Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells. DNA Cell Biol 2004;23:769-76. [PMID: 15585135 DOI: 10.1089/dna.2004.23.769] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
362 Tsai Y, Chang K, Lee H, Cheng Y, Tsai F, Tseng S, Ao HS, Chau PS. Laboratory Science. Effect of p53 codon 72 polymorphism on p53 protein expression in pterygium. Clin Exp Ophthalmol 2005;33:60-2. [DOI: 10.1111/j.1442-9071.2005.00943.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
363 Zhu ZZ, Cong WM, Liu SF, Dong H, Zhu GS, Wu MC. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population. World J Gastroenterol 2005; 11(2): 289-292 [PMID: 15633234 DOI: 10.3748/wjg.v11.i2.289] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
364 Mitra S, Sikdar N, Misra C, Gupta S, Paul RR, Roy B, Panda CK, Roychoudhury S. Risk assessment ofp53 genotypes and haplotypes in tobacco-associated leukoplakia and oral cancer patients from eastern india. Int J Cancer 2005;117:786-93. [DOI: 10.1002/ijc.21263] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
365 Koushik A, Ghosh A, Duarte-franco E, Forest P, Voyer H, Matlashewski G, Coutlée F, Franco EL. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detection and Prevention 2005;29:307-16. [DOI: 10.1016/j.cdp.2005.06.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
366 Zhang X, Miao X, Guo Y, Tan W, Zhou Y, Sun T, Wang Y, Lin D. Genetic polymorphisms in cell cycle regulatory genesMDM2 andTP53 are associated with susceptibility to lung cancer. Hum Mutat 2006;27:110-7. [DOI: 10.1002/humu.20277] [Cited by in Crossref: 110] [Cited by in F6Publishing: 106] [Article Influence: 6.5] [Reference Citation Analysis]
367 Starinsky S, Figer A, Ben-asher E, Geva R, Flex D, Fidder HH, Zidan J, Lancet D, Friedman E. Genotype phenotype correlations in Israeli colorectal cancer patients. Int J Cancer 2005;114:58-73. [DOI: 10.1002/ijc.20645] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
368 Brestovac B, Harnett GB, Smith DW, Shellam GR, Frost FA. Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of Western Australian women. J Med Virol 2005;76:106-10. [DOI: 10.1002/jmv.20330] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
369 Haws ALF, Woeber S, Gomez M, Garza N, Gomez Y, Rady P, He Q, Zhang L, Grady JJ, Mccormick JB, Fisher-hoch SP, Tyring SK. Human papillomavirus infection and P53 codon 72 genotypes in a hispanic population at high-risk for cervical cancer. J Med Virol 2005;77:265-72. [DOI: 10.1002/jmv.20446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
370 Tornesello ML, Waddell KM, Duraturo ML, Biryahwaho B, Downing R, Lucas SB, Giani U, Buonaguro L, Buonaguro FM. TP53 codon 72 polymorphism and risk of conjunctival squamous cell carcinoma in Uganda. Cancer Detection and Prevention 2005;29:501-8. [DOI: 10.1016/j.cdp.2005.08.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
371 van Heemst D, Mooijaart SP, Beekman M, Schreuder J, de Craen AJ, Brandt BW, Eline Slagboom P, Westendorp RG. Variation in the human TP53 gene affects old age survival and cancer mortality. Experimental Gerontology 2005;40:11-5. [DOI: 10.1016/j.exger.2004.10.001] [Cited by in Crossref: 148] [Cited by in F6Publishing: 141] [Article Influence: 8.7] [Reference Citation Analysis]
372 Fonseca-Moutinho JA, Cruz E, Carvalho L, Prazeres HJ, de Lacerda MM, da Silva DP, Mota F, de Oliveira CF. Estrogen receptor, progesterone receptor, and bcl-2 are markers with prognostic significance in CIN III. Int J Gynecol Cancer 2004;14:911-20. [PMID: 15361203 DOI: 10.1111/j.1048-891X.2004.14529.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
373 Pietrowski D, Bettendorf H, Riener EK, Keck C, Hefler LA, Huber JC, Tempfer C. Recurrent pregnancy failure is associated with a polymorphism in the p53 tumour suppressor gene. Hum Reprod 2005;20:848-51. [PMID: 15608028 DOI: 10.1093/humrep/deh696] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
374 Brestovac B, Harnett GB, Smith DW, Frost F, Shellam GR. Multiplex nested PCR (MNP) assay for the detection of 15 high risk genotypes of human papillomavirus. J Clin Virol 2005;33:116-22. [PMID: 15911426 DOI: 10.1016/j.jcv.2004.10.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
375 Hsieh YY, Chang CC, Tsai FJ, Lin CC, Yeh LS, Tsai CH. Tumor necrosis factor-alpha-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas. Fertil Steril 2004;82 Suppl 3:1177-81. [PMID: 15474092 DOI: 10.1016/j.fertnstert.2004.03.035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
376 Comar M, Molin GD, Guaschino S, Campello C. p53 at codon 72 polymorphism, human papillomavirus infection and cervical lesions: a cross-sectional study from northeastern Italy. Eur J Obstet Gynecol Reprod Biol. 2004;114:210-214. [PMID: 15140517 DOI: 10.1016/j.ejogrb.2003.10.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
377 Lung FW, Lee TM, Shu BC, Chang FH. p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan. J Cancer Res Clin Oncol. 2004;130:728-732. [PMID: 15365822 DOI: 10.1007/s00432-004-0605-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
378 Agorastos T, Masouridou S, Lambropoulos AF, Chrisafi S, Miliaras D, Pantazis K, Constantinides TC, Kotsis A, Bontis I. P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women. European Journal of Cancer Prevention 2004;13:277-80. [DOI: 10.1097/01.cej.0000136717.95465.09] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
379 Tsai YY, Tsai YY, Cheng YW, Lee H, Tseng SH, Tsai CH, Tsai FJ. No association of p53 codon 72 and p21 codon 31 polymorphisms in Taiwan Chinese patients with pterygium. Br J Ophthalmol 2004;88:975-6. [PMID: 15205257 DOI: 10.1136/bjo.2003.040428] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
380 Hsia TC, Chiang HC, Chiang D, Hang LW, Tsai FJ, Chen WC. Prediction of survival in surgical unresectable lung cancer by artificial neural networks including genetic polymorphisms and clinical parameters. J Clin Lab Anal. 2003;17:229-234. [PMID: 14614746 DOI: 10.1002/jcla.10102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
381 Settheetham-ishida W, Singto Y, Yuenyao P, Tassaneeyakul W, Kanjanavirojkul N, Ishida T. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand. Cancer Letters 2004;210:205-11. [DOI: 10.1016/j.canlet.2004.03.039] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
382 de Oliveira WRP, Rady PL, Grady J, Hughes TK, Neto CF, Rivitti EA, Tyring SK. Association of p53 arginine polymorphism with skin cancer. Int J Dermatol 2004;43:489-93. [DOI: 10.1111/j.1365-4632.2004.02289.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
383 Ho SH, Jee SH, Lee JE, Park JS. Analysis on risk factors for cervical cancer using induction technique. Expert Systems with Applications 2004;27:97-105. [DOI: 10.1016/j.eswa.2003.12.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
384 Granja F, Morari J, Morari EC, Correa LA, Assumpção LV, Ward LS. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Letters 2004;210:151-7. [DOI: 10.1016/j.canlet.2004.01.016] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
385 Mabrouk I, Baccouche S, El-Abed R, Mokdad-Gargouri R, Mosbah A, Saïd S, Daoud J, Frikha M, Jlidi R, Gargouri A. No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann N Y Acad Sci 2003;1010:764-70. [PMID: 15033824 DOI: 10.1196/annals.1299.137] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 3.2] [Reference Citation Analysis]
386 Katiyar S, Thelma BK, Murthy NS, Hedau S, Jain N, Gopalkrishna V, Husain SA, Das BC. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem 2003;252:117-24. [PMID: 14577584 DOI: 10.1023/a:1025546610920] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.5] [Reference Citation Analysis]
387 Euvrard S, Ulrich C, Lefrancois N. Immunosuppressants and skin cancer in transplant patients: focus on rapamycin. Dermatol Surg. 2004;30:628-633. [PMID: 15061847 DOI: 10.1111/j.1524-4725.2004.30148.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
388 Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MM, Olivier M, Skomedal H, Hainaut P, Tropé CG, Abeler VM, Nesland JM, Børresen-dale A, Helland Å. Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma: TP53 VARIATION AND ADVANCED OVARIAN CANCER. Hum Mutat 2004;24:21-34. [DOI: 10.1002/humu.20055] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
389 Lee JE, Lee SJ, Namkoong SE, Um SJ, Sull JW, Jee SH, You YK, Park JS. Gene-gene and gene-environmental interactions of p53, p21, and IRF-1 polymorphisms in Korean women with cervix cancer. Int J Gynecol Cancer 2004;14:118-25. [PMID: 14764039 DOI: 10.1111/j.1048-891x.2004.014040.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
390 Lee SA, Kim JW, Roh JW, Choi JY, Lee KM, Yoo KY, Song YS, Kang D. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women. Gynecol Oncol. 2004;93:14-18. [PMID: 15047208 DOI: 10.1016/j.ygyno.2003.11.045] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
391 Zoodsma M, Sijmons RH, de Vries EG, Zee AG. Familial cervical cancer: case reports, review and clinical implications. Hered Cancer Clin Pract 2004;2:99-105. [PMID: 20233477 DOI: 10.1186/1897-4287-2-2-99] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
392 Gemignani F, Moreno V, Landi S, Moullan N, Chabrier A, Gutiérrez-Enríquez S, Hall J, Guino E, Peinado MA, Capella G. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene. 2004;23:1954-1956. [PMID: 14647431 DOI: 10.1038/sj.onc.1207305] [Cited by in Crossref: 147] [Cited by in F6Publishing: 132] [Article Influence: 8.2] [Reference Citation Analysis]
393 Bonafé M, Salvioli S, Barbi C, Trapassi C, Tocco F, Storci G, Invidia L, Vannini I, Rossi M, Marzi E, Mishto M, Capri M, Olivieri F, Antonicelli R, Memo M, Uberti D, Nacmias B, Sorbi S, Monti D, Franceschi C. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. Cell Death Differ 2004;11:962-73. [DOI: 10.1038/sj.cdd.4401415] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
394 Zhang ZW, Newcomb P, Hollowood A, Moganaden, Gupta J, Feakins R, Storey A, Farthing MJ, Alderson D, Holly J. A comparison study of gastric cancer risk in patients with duodenal and gastric ulcer: roles of gastric mucosal histology and p53 codon 72 polymorphism. Dig Dis Sci 2004;49:254-9. [PMID: 15104366 DOI: 10.1023/b:ddas.0000017447.02220.f5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
395 Zhang ZW, Newcomb P, Hollowood A, Moganaden J, Feakins R, Storey A, Farthing MJ, Alderson D, Holly J. A comparison study of gastric cancer risk in patients with duodenal and gastric ulcer: roles of gastric mucosal histology and p53 codon 72 polymorphism. Dig Dis Sci. 2004;49:254-259. [PMID: 15104366 DOI: 10.1023/B: DDAS.0000017447.02220.f5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
396 Schreiber K, Cannon RE, Karrison T, Beck-engeser G, Huo D, Tennant RW, Jensen H, Kast WM, Krausz T, Meredith SC, Chen L, Schreiber H. Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors. Oncogene 2004;23:3972-9. [DOI: 10.1038/sj.onc.1207507] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
397 Euvrard S, Ulrich C, Lefrancois N. Immunosuppressants and Skin Cancer in Transplant Patients: Focus on Rapamycin. Dermatologic Surgery 2004;30:628-33. [DOI: 10.1097/00042728-200404020-00010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
398 Cortezzi SS, Provazzi PJ, Sobrinho JS, Mann-prado JC, Reis PMP, Freitas SEND, Filho JFG, Fukuyama ÉE, Cordeiro JA, Cury PM, Maniglia JV, Villa LL, Tajara EH, Rahal P. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas. Cancer Genetics and Cytogenetics 2004;150:44-9. [DOI: 10.1016/j.cancergencyto.2003.07.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
399 Tiersma ES, van der Lee ML, Peters AA, Visser AP, Jan Fleuren G, Garssen B, van Leeuwen KM, le Cessie S, Goodkin K. Psychosocial factors and the grade of cervical intra-epithelial neoplasia: a semi-prospective study. Gynecol Oncol 2004;92:603-10. [PMID: 14766254 DOI: 10.1016/j.ygyno.2003.10.046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
400 Buchinsky FJ, Derkay CS, Leal SM, Donfack J, Ehrlich GD, Post JC. Multicenter initiative seeking critical genes in respiratory papillomatosis. Laryngoscope 2004;114:349-57. [PMID: 14755217 DOI: 10.1097/00005537-200402000-00032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
401 Suzuki K, Matsui H, Ohtake N, Nakata S, Takei T, Nakazato H, Okugi H, Koike H, Ono Y, Ito K. A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese. J Biomed Sci. 2003;10:430-435. [PMID: 12824702 DOI: 10.1007/bf02256434] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
402 Hernádi Z, Sápy T, Krasznai ZT. The prevalence of the HPV 16 genome, integrated viral status and p53 genotype in cervical cancer population of north-eastern Hungary, the correlation with the established markers of tumour progression. European Journal of Obstetrics & Gynecology and Reproductive Biology 2004;113:83-6. [DOI: 10.1016/j.ejogrb.2003.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
403 Niwa Y, Hamajima N, Atsuta Y, Yamamoto K, Tamakoshi A, Saito T, Hirose K, Nakanishi T, Nawa A, Kuzuya K, Tajima K. Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. Cancer Letters 2004;205:55-60. [DOI: 10.1016/j.canlet.2003.11.014] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
404 Huang XE, Hamajima N, Katsuda N, Matsuo K, Hirose K, Mizutani M, Iwata H, Miura S, Xiang J, Tokudome S, Tajima K. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer 2003;10:307-11. [PMID: 14634508 DOI: 10.1007/BF02967650] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 3.6] [Reference Citation Analysis]
405 Zee RY, Cook NR, Kim CA, Fernandez-Cruz A, Lindpaintner K. TP53 haplotype-based analysis and incidence of post-angioplasty restenosis. Hum Genet 2004;114:386-90. [PMID: 14740296 DOI: 10.1007/s00439-003-1080-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
406 Tao M, Kruhlak M, Xia S, Androphy E, Zheng ZM. Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells. J Virol 2003;77:13232-47. [PMID: 14645580 DOI: 10.1128/jvi.77.24.13232-13247.2003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.2] [Reference Citation Analysis]
407 Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 2004;108:196-9. [PMID: 14639602 DOI: 10.1002/ijc.11548] [Cited by in Crossref: 271] [Cited by in F6Publishing: 273] [Article Influence: 15.1] [Reference Citation Analysis]
408 Agirre X, Novo FJ, Calasanz MJ, Larráyoz MJ, Lahortiga I, Valgañón M, García-Delgado M, Vizmanos JL. TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia. Mol Carcinog 2003;38:201-8. [PMID: 14639659 DOI: 10.1002/mc.10159] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
409 Brenna SMF, Silva IDCGD, Zeferino LC, Pereira J, Martinez EZ, Syrjänen KJ. Prevalence of codon 72 P53 polymorphism in Brazilian women with cervix cancer. Genet Mol Biol 2004;27:496-9. [DOI: 10.1590/s1415-47572004000400005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
410 Nichols KE, Heath JA, Friedman D, Biegel JA, Ganguly A, Mauch P, Diller L. TP53, BRCA1 , and BRCA2 Tumor Suppressor Genes Are Not Commonly Mutated in Survivors of Hodgkin’s Disease With Second Primary Neoplasms. JCO 2003;21:4505-9. [DOI: 10.1200/jco.2003.12.042] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
411 Jee S, Won S, Yun J, Lee J, Park J, Ji S. Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis. International Journal of Gynecology & Obstetrics 2004;85:301-8. [DOI: 10.1016/j.ijgo.2003.08.017] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
412 Das S, El-deiry WS, Somasundaram K. Efficient growth inhibition of HPV 16 E6-expressing cells by an adenovirus-expressing p53 homologue p73β. Oncogene 2003;22:8394-402. [DOI: 10.1038/sj.onc.1206908] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
413 Ueda M, Hung Y, Term Y, Kanda K, Takehara M, Yamashita H, Yamaguchi H, Akise D, Yasuda M, Nishiyama K, Ueki M. Glutathione S-Transferase GSTM1, GSTT1 and p53 Codon 72 Polymorphisms in Human Tumor Cells. Human Cell 2003;16:241-51. [DOI: 10.1111/j.1749-0774.2003.tb00158.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
414 Willis AC, Pipes T, Zhu J, Chen X. p73 can suppress the proliferation of cells that express mutant p53. Oncogene. 2003;22:5481-5495. [PMID: 12934108 DOI: 10.1038/sj.onc.1206505] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
415 Su L, Sai Y, Fan R, Thurston SW, Miller DP, Zhou W, Wain JC, Lynch TJ, Liu G, Christiani DC. P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21. Lung Cancer 2003;40:259-66. [PMID: 12781424 DOI: 10.1016/s0169-5002(03)00081-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
416 Franco EL, Schlecht NF, Saslow D. The Epidemiology of Cervical Cancer: . The Cancer Journal 2003;9:348-59. [DOI: 10.1097/00130404-200309000-00004] [Cited by in Crossref: 142] [Cited by in F6Publishing: 140] [Article Influence: 7.5] [Reference Citation Analysis]
417 Altiok S. Molecular markers in cervical cytology. Clinics in Laboratory Medicine 2003;23:709-28. [DOI: 10.1016/s0272-2712(03)00055-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
418 Black AP, Ogg GS. The role of p53 in the immunobiology of cutaneous squamous cell carcinoma. Clin Exp Immunol 2003;132:379-84. [PMID: 12780682 DOI: 10.1046/j.1365-2249.2003.02159.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
419 Sindos M, Ndisang D, Pisal N, Chow C, Singer A, Latchman DS. Measurement of Brn-3a levels in Pap smears provides a novel diagnostic marker for the detection of cervical neoplasia. Gynecologic Oncology 2003;90:366-71. [DOI: 10.1016/s0090-8258(03)00261-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
420 Cho NH, Lim SY, Kim YT, Kim D, Kim YS, Kim JW. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value. Gynecol Oncol 2003;90:15-22. [PMID: 12821336 DOI: 10.1016/s0090-8258(03)00198-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
421 Moodley M, Moodley J, Chetty R, Herrington CS. The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int J Gynecol Cancer 2003;13:103-10. [PMID: 12657108 DOI: 10.1046/j.1525-1438.2003.13030.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
422 Tiwawech D, Srivatanakul P, Karaluk A, Ishida T. The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma. Cancer Letters 2003;198:69-75. [DOI: 10.1016/s0304-3835(03)00283-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
423 Gasco M, Crook T. The p53 network in head and neck cancer. Oral Oncol. 2003;39:222-231. [PMID: 12618194 DOI: 10.1016/s1368-8375(02)00163-x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 85] [Article Influence: 5.1] [Reference Citation Analysis]
424 Koref MS, Gangeswaran R, Koref IS, Shanahan N, Hancock J. A phylogenetic approach to assessing the significance of missense mutations in disease genes. Hum Mutat 2003;22:51-8. [DOI: 10.1002/humu.10235] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
425 Bosch FX, de Sanjose S. Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality. JNCI Monographs 2003;2003:3-13. [DOI: 10.1093/oxfordjournals.jncimonographs.a003479] [Cited by in Crossref: 519] [Cited by in F6Publishing: 471] [Article Influence: 27.3] [Reference Citation Analysis]
426 Wen Cheng Y, Lee H. Environmental Exposure and Lung Cancer Among Nonsmokers: An Example of Taiwanese Female Lung Cancer. Journal of Environmental Science and Health, Part C 2003;21:1-28. [DOI: 10.1081/gnc-120021371] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
427 Humbey O, Cairey-Remonnay S, Guérrini JS, Algros MP, Mougin C, Bittard H, Aubin F. Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas. Eur J Cancer. 2003;39:684-690. [PMID: 12628849 DOI: 10.1016/s0959-8049(02)00835-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
428 Govan VA, Carrara HR, Sachs JA, Hoffman M, Stanczuk GA, Williamson AL. Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog. 2003;2:3. [PMID: 12809559 DOI: 10.1186/1477-3163-2-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
429 Jee SH, Lee JE, Park JS. Polymorphism of codon 72 of p53 and environmental factors in the development of cervical cancer. Int J Gynaecol Obstet 2003;80:69-70. [PMID: 12527466 DOI: 10.1016/s0020-7292(02)00302-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
430 Wang XL, Raveendran M, Wang J. Genetic influence on cigarette-induced cardiovascular disease. Prog Cardiovasc Dis 2003;45:361-82. [PMID: 12704594 DOI: 10.1053/pcad.2003.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
431 Nagpal JK, Sahni S, Das BR. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women. Eur J Clin Invest 2002;32:943-8. [PMID: 12534455 DOI: 10.1046/j.1365-2362.2002.01096.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
432 Pöschel T, Freund JA. How to decide whether small samples comply with an equidistribution. Biosystems 2003;69:63-72. [PMID: 12648853 DOI: 10.1016/s0303-2647(03)00030-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
433 Arbel-Alon S, Menczer J, Feldman N, Glezerman M, Yeremin L, Friedman E. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women. Int J Gynecol Cancer 2002;12:741-4. [PMID: 12445252 DOI: 10.1046/j.1525-1438.2002.01124.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
434 Vos M, Adams CH, Victor TC, van Helden PD. Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. Cancer Genet Cytogenet. 2003;140:23-30. [PMID: 12550754 DOI: 10.1016/s0165-4608(02)00638-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
435 Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A, Zehbe I. The role of TP53 in Cervical carcinogenesis. Hum Mutat 2003;21:307-12. [DOI: 10.1002/humu.10178] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 5.1] [Reference Citation Analysis]
436 Alamartine E, Berthoux P, Mariat C, Cambazard F, Berthoux F. Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation. J Invest Dermatol 2003;120:99-103. [PMID: 12535204 DOI: 10.1046/j.1523-1747.2003.12016.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 3.0] [Reference Citation Analysis]
437 Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357-365. [PMID: 12567188 DOI: 10.1038/ng1093] [Cited by in Crossref: 864] [Cited by in F6Publishing: 850] [Article Influence: 45.5] [Reference Citation Analysis]
438 Hernadi Z, Szarka K, Sapy T, Krasznai Z, Veress G, Poka R. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up. BJOG: An Internal Journal of Obs Gyn 2003;110:205-9. [DOI: 10.1046/j.1471-0528.2003.01516.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
439 Bhattacharya P, Duttagupta C, Sengupta S. Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women. Cancer Lett 2002;188:207-11. [PMID: 12406566 DOI: 10.1016/s0304-3835(02)00430-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
440 Li T, Lu ZM, Guo M, Wu QJ, Chen KN, Xing HP, Mei Q, Ke Y. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer. 2002;95:2571-2576. [PMID: 12467072 DOI: 10.1002/cncr.11008] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 3.0] [Reference Citation Analysis]
441 Mcdonnell TJ, O'connor S. Is the polymorphic arginine form of p53 a risk factor for renal transplant patients?: . Advances in Anatomic Pathology 2003;10:50. [DOI: 10.1097/00125480-200301000-00010] [Reference Citation Analysis]
442 Schneider A, Gissmann L. Cervical Cancer: The Potential Role of Human Papillomavirus (HPV)-Specific Vaccines in Prevention and Treatment. American Journal of Cancer 2003;2:253-68. [DOI: 10.2165/00024669-200302040-00004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
443 Baccouche S, Mabrouk I, Said S, Mosbah A, Jlidi R, Gargouri A. A more accurate detection of codon 72 polymorphism and LOH of the TP53 gene. Cancer Letters 2003;189:91-6. [DOI: 10.1016/s0304-3835(02)00405-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
444 Papadakis ED, Soulitzis N, Spandidos DA. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br J Cancer. 2002;87:1013-1018. [PMID: 12434294 DOI: 10.1038/sj.bjc.6600595] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 3.2] [Reference Citation Analysis]
445 Suspitsin EN, Buslov KG, Grigoriev MY, Ishutkina JG, Ulibina JM, Gorodinskaya VM, Pozharisski KM, Berstein LM, Hanson KP, Togo AV, Imyanitov EN. Evidence against involvement of p53 polymorphism in breast cancer predisposition. Int J Cancer 2003;103:431-3. [DOI: 10.1002/ijc.10834] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
446 Park RB, Androphy EJ. Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J Virol 2002;76:11359-64. [PMID: 12388696 DOI: 10.1128/jvi.76.22.11359-11364.2002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 3.0] [Reference Citation Analysis]
447 Bonafè M, Salvioli S, Barbi C, Mishto M, Trapassi C, Gemelli C, Storci G, Olivieri F, Monti D, Franceschi C. p53 codon 72 genotype affects apoptosis by cytosine arabinoside in blood leukocytes. Biochemical and Biophysical Research Communications 2002;299:539-41. [DOI: 10.1016/s0006-291x(02)02691-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
448 Sanclemente G, Gill DK. Human papillomavirus molecular biology and pathogenesis. J Eur Acad Dermatol Venereol. 2002;16:231-240. [PMID: 12195562 DOI: 10.1046/j.1473-2165.2002.00419.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
449 Robles AI, Linke SP, Harris CC. The p53 network in lung carcinogenesis. Oncogene 2002;21:6898-907. [DOI: 10.1038/sj.onc.1205563] [Cited by in Crossref: 102] [Cited by in F6Publishing: 84] [Article Influence: 5.1] [Reference Citation Analysis]
450 Bonafè M, Barbi C, Storci G, Salvioli S, Capri M, Olivieri F, Valensin S, Monti D, Gonos ES, De Benedictis G, Franceschi C. What studies on human longevity tell us about the risk for cancer in the oldest old: data and hypotheses on the genetics and immunology of centenarians. Experimental Gerontology 2002;37:1263-71. [DOI: 10.1016/s0531-5565(02)00137-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
451 Davy CE, Jackson DJ, Wang Q, Raj K, Masterson PJ, Fenner NF, Southern S, Cuthill S, Millar JB, Doorbar J. Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. J Virol 2002;76:9806-18. [PMID: 12208959 DOI: 10.1128/jvi.76.19.9806-9818.2002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]
452 Pegoraro RJ, Rom L, Lanning PA, Moodley M, Naiker S, Moodley J. P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women. Int J Gynecol Cancer 2002;12:383-8. [PMID: 12144687 DOI: 10.1046/j.1525-1438.2002.01109.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
453 Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett 2002;183:123-30. [PMID: 12065086 DOI: 10.1016/s0304-3835(02)00117-9] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 3.2] [Reference Citation Analysis]
454 Bouwes Bavinck JN, Feltkamp M, Struijk L, ter Schegget J. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Investig Dermatol Symp Proc. 2001;6:207-211. [PMID: 11924829 DOI: 10.1046/j.0022-202x.2001.00048.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 65] [Article Influence: 4.4] [Reference Citation Analysis]
455 Manfredi S, Masetti S, Botto N, Colombo MG, Terrazzi M, Vassalle C, Biagini A, Andreassi MG. p53 codon 72 polymorphism in coronary artery disease: No evidence for association with increased risk or micronucleus frequency. Environ Mol Mutagen 2002;40:110-5. [DOI: 10.1002/em.10098] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
456 Saranath D, Khan Z, Tandle AT, Dedhia P, Sharma B, Contractor R, Shrivastava S, Dinshaw K. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India. Gynecol Oncol. 2002;86:157-162. [PMID: 12144822 DOI: 10.1006/gyno.2002.6735] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.0] [Reference Citation Analysis]
457 Lin HJ, Chen WC, Tsai FJ, Tsai SW. Distributions of p53 codon 72 polymorphism in primary open angle glaucoma. Br J Ophthalmol 2002;86:767-70. [PMID: 12084746 DOI: 10.1136/bjo.86.7.767] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
458 Calhoun ES, Mcgovern RM, Janney CA, Cerhan JR, Iturria SJ, Smith DI, Gostout BS, Persing DH. Host Genetic Polymorphism Analysis in Cervical Cancer. Clinical Chemistry 2002;48:1218-24. [DOI: 10.1093/clinchem/48.8.1218] [Cited by in Crossref: 52] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
459 Kim HT, Tasca S, Qiang W, Wong PK, Stoica G. Induction of p53 accumulation by Moloney murine leukemia virus-ts1 infection in astrocytes via activation of extracellular signal-regulated kinases 1/2. Lab Invest 2002;82:693-702. [PMID: 12065679 DOI: 10.1097/01.lab.0000017373.82871.45] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
460 Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, Shimamoto F, Haruma K, Chayama K. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients withHelicobacter pylori-associated chronic gastritis. Int J Cancer 2002;100:304-8. [DOI: 10.1002/ijc.10483] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 2.7] [Reference Citation Analysis]
461 Mcgregor JM, Harwood CA, Brooks L, Kelly DA, O’nions J, Young AR, Surentheran T, Breuer J, Millard TP, Lewis CM, Leigh IM, Storey A, Crook T, Fisher SA. Relationship Between p53 Codon 72 Polymorphism and Susceptibility to Sunburn and Skin Cancer. Journal of Investigative Dermatology 2002;119:84-90. [DOI: 10.1046/j.1523-1747.2002.01655.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 302] [Article Influence: 3.1] [Reference Citation Analysis]
462 Tõnisson N, Zernant J, Kurg A, Pavel H, Slavin G, Roomere H, Meiel A, Hainaut P, Metspalu A. Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene. Proc Natl Acad Sci U S A 2002;99:5503-8. [PMID: 11960007 DOI: 10.1073/pnas.082100599] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
463 Horn LC, Raptis G, Fischer U. Familial cancer history in patients with carcinoma of the cervix uteri. Eur J Obstet Gynecol Reprod Biol 2002;101:54-7. [PMID: 11803100 DOI: 10.1016/s0301-2115(01)00520-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
464 Cairey-remonnay S, Humbey O, Mougin C, Algros MP, Mauny F, Kanitakis J, Euvrard S, Laurent R, Aubin F. TP53 Polymorphism of Exon 4 at Codon 72 in Cutaneous Squamous Cell Carcinoma and Benign Epithelial Lesions of Renal Transplant Recipients and Immunocompetent Individuals: Lack of Correlation with Human Papillomavirus Status11This work was presented in part at the 19th International Papillomavirus Conference in Florianopolis, Brazil, September 1–7, 2001. Journal of Investigative Dermatology 2002;118:1026-31. [DOI: 10.1046/j.1523-1747.2002.01787.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
465 Humbey O, Aubin F, Cairey-remonnay S, Riethmuller D, Pretet JL, Fest T, Seilles E, Mougin C. TP53 polymorphism at exon 4 in caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions. European Journal of Obstetrics & Gynecology and Reproductive Biology 2002;103:60-4. [DOI: 10.1016/s0301-2115(02)00006-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
466 Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65. [PMID: 11919208 DOI: 10.1136/jcp.55.4.244] [Cited by in Crossref: 2079] [Cited by in F6Publishing: 1938] [Article Influence: 104.0] [Reference Citation Analysis]
467 Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA. p53 codon 72 polymorphism and its association with bladder cancer. Cancer Letters 2002;179:175-83. [DOI: 10.1016/s0304-3835(01)00867-9] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 4.6] [Reference Citation Analysis]
468 Brenna SMF, Zeferino LC, Pinto GA, Souza RA, Andrade LAL, Vassalo J, Martinez EZ, Syrjanen KJ. P53 expression as a predictor of recurrence in cervical squamous cell carcinoma. Int J Gynecol Cancer 2002;12:299-303. [DOI: 10.1046/j.1525-1438.2002.01097.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
469 Trikka D, Fang Z, Renwick A, Jones SH, Chakraborty R, Kimmel M, Nelson DL. Complex SNP-based haplotypes in three human helicases: implications for cancer association studies. Genome Res 2002;12:627-39. [PMID: 11932247 DOI: 10.1101/gr.176702] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
470 Schwartz LM, Nambu JR, Wang Z. Parkinsonism proteolysis and proteasomes. Cell Death Differ 2002;9:479-82. [DOI: 10.1038/sj.cdd.4401026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
471 Soussi T, Béroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001;1:233-40. [PMID: 11902578 DOI: 10.1038/35106009] [Cited by in Crossref: 444] [Cited by in F6Publishing: 405] [Article Influence: 22.2] [Reference Citation Analysis]
472 Riethmuller D, Schaal JP, Mougin C. [Epidemiology and natural history of genital infection by human papillomavirus]. Gynecol Obstet Fertil 2002;30:139-46. [PMID: 11910884 DOI: 10.1016/s1297-9589(01)00282-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
473 Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer: . Current Opinion in Infectious Diseases 2002;15:101-14. [DOI: 10.1097/00001432-200204000-00002] [Cited by in Crossref: 144] [Cited by in F6Publishing: 116] [Article Influence: 7.2] [Reference Citation Analysis]
474 Brentjens MH, Yeung-yue KA, Lee PC, Tyring SK. Human papillomavirus: a review. Dermatologic Clinics 2002;20:315-31. [DOI: 10.1016/s0733-8635(01)00028-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
475 Tsai MH, Lin CD, Hsieh YY, Chang FC, Tsai FJ, Chen WC, Tsai CH. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope. 2002;112:116-119. [PMID: 11802048 DOI: 10.1097/00005537-200201000-00020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
476 Portwine C, Chilton-MacNeill S, Brown C, Sexsmith E, McLaughlin J, Malkin D. Absence of germline and somatic p53 alterations in children with sporadic brain tumors. J Neurooncol 2001;52:227-35. [PMID: 11519852 DOI: 10.1023/a:1010661831335] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
477 Nagpal JK, Patnaik S, Das BR. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (oscc) patients of Eastern India. Int J Cancer 2002;97:649-53. [DOI: 10.1002/ijc.10112] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 3.9] [Reference Citation Analysis]
478 Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 2001;20:7874-7887. [PMID: 11753670 DOI: 10.1038/sj.onc.1204869] [Cited by in Crossref: 318] [Cited by in F6Publishing: 305] [Article Influence: 15.9] [Reference Citation Analysis]
479 Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. The Lancet Oncology 2002;3:11-6. [DOI: 10.1016/s1470-2045(01)00617-9] [Cited by in Crossref: 140] [Cited by in F6Publishing: 129] [Article Influence: 7.0] [Reference Citation Analysis]
480 Guimaraes D, Hainaut P. TP53: a key gene in human cancer. Biochimie 2002;84:83-93. [DOI: 10.1016/s0300-9084(01)01356-6] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 5.2] [Reference Citation Analysis]
481 Chang C, Hsieh Y, Tsai F, Tsai C, Tsai H, Lin C. The proline form of p53 codon 72 polymorphism is associated with endometriosis. Fertility and Sterility 2002;77:43-5. [DOI: 10.1016/s0015-0282(01)02938-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 2.7] [Reference Citation Analysis]
482 Griffiths, Mellon. Human papillomavirus and urological tumours: I. Basic science and role in penile cancer: HPV AND UROLOGICAL TUMOURS. BJU International 1999;84:579-86. [DOI: 10.1046/j.1464-410x.1999.00271.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
483 Forslund O, Nordin P, Hansson B. Mucosal human papillomavirus types in squamous cell carcinomas of the uterine cervix and subsequently on fingers: HPV IN CERVICAL and DIGITAL SCC. British Journal of Dermatology 2000;142:1148-53. [DOI: 10.1046/j.1365-2133.2000.03540.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
484 Kaye FJ. Publishing Negative Data:  -Tubulin Mutations in Lung Cancer. JNCI Journal of the National Cancer Institute 2001;93:1832-3. [DOI: 10.1093/jnci/93.24.1832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
485 Andersson S, Rylander E, Strand A, Sällström J, Wilander E. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas. Br J Cancer 2001;85:1153-6. [PMID: 11710828 DOI: 10.1054/bjoc.2001.2085] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
486 Okada F, Shiraki T, Maekawa M, Sato S. A p53 polymorphism associated with increased risk of hepatitis C virus infection. Cancer Lett. 2001;172:137-142. [PMID: 11566488 DOI: 10.1016/s0304-3835(01)00653-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
487 Sourvinos G, Rizos E, Spandidos D. p53 codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours. Oral Oncology 2001;37:572-8. [DOI: 10.1016/s1368-8375(00)00139-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
488 Gastrell FH, Mcconnell DT. Human papillomavirus and vulval intra-epithelial neoplasia. Best Practice & Research Clinical Obstetrics & Gynaecology 2001;15:769-82. [DOI: 10.1053/beog.2001.0219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
489 Ndisang D, Budhram-mahadeo V, Pedley B, Latchman DS. The Brn-3a transcription factor plays a key role in regulating the growth of cervical cancer cells in vivo. Oncogene 2001;20:4899-903. [DOI: 10.1038/sj.onc.1204634] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
490 O'Connor DP, Kay EW, Leader M, Atkins GJ, Murphy GM, Mabruk MJ. p53 codon 72 polymorphism and human papillomavirus associated skin cancer. J Clin Pathol 2001;54:539-42. [PMID: 11429426 DOI: 10.1136/jcp.54.7.539] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 1.8] [Reference Citation Analysis]
491 Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW, Shen CY. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene. 2001;20:3814-3823. [PMID: 11439345 DOI: 10.1038/sj.onc.1204505] [Cited by in Crossref: 156] [Cited by in F6Publishing: 150] [Article Influence: 7.4] [Reference Citation Analysis]
492 Cho Y, Kang J, Cho M, Cho C, Lee S, Choe Y, Kim Y, Choi I, Park S, Kim S, Dinarello CA, Yoon D. Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Letters 2001;501:139-45. [DOI: 10.1016/s0014-5793(01)02652-7] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
493 Haensgen G, Krause U, Becker A, Stadler P, Lautenschlaeger C, Wohlrab W, Rath FW, Molls M, Dunst J. Tumor hypoxia, p53, and prognosis in cervical cancers. International Journal of Radiation Oncology*Biology*Physics 2001;50:865-72. [DOI: 10.1016/s0360-3016(01)01523-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
494 Tandle AT, Sanghvi V, Saranath D. Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 2001;84:739-42. [PMID: 11259085 DOI: 10.1054/bjoc.2000.1674] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
495 Peixoto Guimaraes D, Hsin Lu S, Snijders P, Wilmotte R, Herrero R, Lenoir G, Montesano R, Meijer CJ, Walboomers J, Hainaut P. Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett. 2001;162:231-235. [PMID: 11146230 DOI: 10.1016/s0304-3835(00)00643-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
496 Jefferies S, Foulkes W. Genetic mechanisms in squamous cell carcinoma of the head and neck. Oral Oncology 2001;37:115-26. [DOI: 10.1016/s1368-8375(00)00065-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
497 Jackson S, Harwood C, Thomas M, Banks L, Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 2000;14:3065-3073. [PMID: 11114894 DOI: 10.1101/gad.182100] [Cited by in Crossref: 234] [Cited by in F6Publishing: 209] [Article Influence: 11.1] [Reference Citation Analysis]
498 Henner WD, Evans AJ, Hough KM, Harris EL, Lowe BA, Beer TM. Association of codon 72 polymorphism of p53 with lower prostate cancer risk. Prostate 2001;49:263-6. [DOI: 10.1002/pros.10021] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.4] [Reference Citation Analysis]
499 Giannoudis A, Simon Herrington C. Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 2001;193:295-302. [DOI: 10.1002/1096-9896(2000)9999:9999<::aid-path809>3.0.co;2-c] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 3.5] [Reference Citation Analysis]
500 Follen M, Schottenfeld D. Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials. Cancer 2001;91:1758-76. [DOI: 10.1002/1097-0142(20010501)91:9<1758::aid-cncr1195>3.0.co;2-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
501 Bastiaens MT, Struyk L, Tjong-a-hung SP, Gruis N, ter Huurne J, Westendorp RGJ, Vermeer BJ, Bavinck JNB, ter Schegget J. Cutaneous squamous cell carcinoma andp53 codon 72 polymorphism: A need for screening? Mol Carcinog 2001;30:56-61. [DOI: 10.1002/1098-2744(200101)30:1<56::aid-mc1013>3.0.co;2-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
502 Kim JW, Roh JW, Park NH, Song YS, Kang SB, Lee HP. Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women. Am J Obstet Gynecol 2001;184:55-8. [PMID: 11174479 DOI: 10.1067/mob.2001.108329] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
503 Kang JK, Kim JH, Lee SH, Kim DH, Kim HS, Lee JE, Seo JS. Development of spontaneous hyperplastic skin lesions and chemically induced skin papillomas in transgenic mice expressing human papillomavirus type 16 E6/E7 genes. Cancer Lett. 2000;160:177-183. [PMID: 11053647 DOI: 10.1016/S0304-3835(00)00575-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
504 Bonnen PE, Story MD, Ashorn CL, Buchholz TA, Weil MM, Nelson DL. Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium. Am J Hum Genet 2000;67:1437-51. [PMID: 11078475 DOI: 10.1086/316908] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.1] [Reference Citation Analysis]
505 Warenius HM, Jones M, Gorman T, McLeish R, Seabra L, Barraclough R, Rudland P. Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity. Br J Cancer 2000;83:1084-95. [PMID: 10993658 DOI: 10.1054/bjoc.2000.1409] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
506 Lee JM, Lee YC, Yang SY, Shi WL, Lee CJ, Luh SP, Chen CJ, Hsieh CY, Wu MT. Genetic polymorphisms of p53 and GSTP1, but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer. 2000;89:458-464. [PMID: 11008209 DOI: 10.1002/1097-0215(20000920)89:5%3C458::AID-IJC10%3E3.0.CO;2-R] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
507 Pegoraro R, Moodley J, Naiker S, Lanning P, Rom L. The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer. BJOG 2000;107:1164-5. [PMID: 11002963 DOI: 10.1111/j.1471-0528.2000.tb11118.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
508 Agorastos T, Lambropoulos AF, Constantinidis TC, Kotsis A, Bontis JN. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Eur J Cancer Prev 2000;9:113-8. [PMID: 10830578 DOI: 10.1097/00008469-200004000-00007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
509 Thompson-Hehir J, Davies MP, Green JA, Halliwell N, Joyce KA, Salisbury J, Sibson DR, Vergote I, Walker C. Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors. Diagn Mol Pathol 2000;9:110-9. [PMID: 10850547 DOI: 10.1097/00019606-200006000-00007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
510 Nishikawa A, Fujimoto T, Akutagawa N, Iwasaki M, Takeuchi M, Fujinaga K, Kudo R. p53 Polymorphism (codon-72) has no correlation with the development and the clinical features of cervical cancer. Int J Gynecol Cancer 2000;10:402-7. [PMID: 11240705 DOI: 10.1046/j.1525-1438.2000.010005402.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
511 Summersgill KF, Smith EM, Kirchner H, Haugen TH, Turek LP. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2000;90:334-9. [DOI: 10.1067/moe.2000.107359] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 2.0] [Reference Citation Analysis]
512 Dokianakis DN, Spandidos DA. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer. Mol Cell Biol Res Commun 2000;3:111-4. [PMID: 10775508 DOI: 10.1006/mcbr.2000.0196] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
513 Kojima S, Goto Y, Nonogi H, Horie H, Kinoshita M, Iwai N. Role of a p53 polymorphism in luminal narrowing after balloon coronary angioplasty. Atherosclerosis 2000;151:585-6. [DOI: 10.1016/s0021-9150(00)00452-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
514 Lin WM, Ashfaq R, Michalopulos EA, Maitra A, Gazdar AF, Muller CY. Molecular Papanicolaou tests in the twenty-first century: molecular analyses with fluid-based Papanicolaou technology. Am J Obstet Gynecol 2000;183:39-45. [PMID: 10920306 DOI: 10.1067/mob.2000.105734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
515 Khaliq S, Hameed A, Khaliq T, Ayub Q, Qamar R, Mohyuddin A, Mazhar K, Qasim-Mehdi S. P53 mutations, polymorphisms, and haplotypes in Pakistani ethnic groups and breast cancer patients. Genet Test 2000;4:23-9. [PMID: 10794357 DOI: 10.1089/109065700316435] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
516 Malcolm EK, Baber GB, Boyd JC, Stoler MH. Polymorphism at codon 72 of p53 is not associated with cervical cancer risk. Mod Pathol 2000;13:373-8. [PMID: 10786802 DOI: 10.1038/modpathol.3880061] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
517 Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, DeVoe G, Miller MA, Wang J, Noffsinger A. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology. 2000;118:1039-1044. [PMID: 10833478 DOI: 10.1016/s0016-5085(00)70356-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.6] [Reference Citation Analysis]
518 Roth J, Koch P, Contente A, Dobbelstein M. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain. Oncogene 2000;19:1834-42. [PMID: 10777217 DOI: 10.1038/sj.onc.1203500] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
519 Pinto AP, Crum CP. Natural History of Cervical Neoplasia: Defining Progression and Its Consequence: . Clinical Obstetrics and Gynecology 2000;43:352-62. [DOI: 10.1097/00003081-200006000-00015] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 3.3] [Reference Citation Analysis]
520 Papadakis E, Dokianakis D, Spandidos D. p53 Codon 72 Polymorphism as a Risk Factor in the Development of Breast Cancer. Molecular Cell Biology Research Communications 2000;3:389-92. [DOI: 10.1006/mcbr.2000.0241] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 3.7] [Reference Citation Analysis]
521 Kim JW, Lee CG, Park YG, Kim KS, Kim IK, Sohn YW, Min HK, Lee JM, Namkoong SE. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer 2000;88:2082-91. [PMID: 10813720 DOI: 10.1002/(sici)1097-0142(20000501)88:9<2082::aid-cncr14>3.0.co;2-d] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 3.1] [Reference Citation Analysis]
522 Mclachlin CM. Human Papillomavirus in Cervical Neoplasia: Role, Risk Factors, and Implications. Clinics in Laboratory Medicine 2000;20:257-70. [DOI: 10.1016/s0272-2712(18)30061-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
523 Starkey WG, Mant C, Best JM, Banatvala JE, Muir P, Cason J, Bible JM, Biswas C, Shanti Raju K, Kell B, Seed P. Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. Journal of General Virology 2000;81:1517-27. [DOI: 10.1099/0022-1317-81-6-1517] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
524 Tewari KS, Taylor JA, Liao SY, DiSaia PJ, Burger RA, Monk BJ, Hughes CC, Villarreal LP. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model. Gynecol Oncol 2000;77:137-48. [PMID: 10739703 DOI: 10.1006/gyno.2000.5729] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
525 Mantovani F, Banks L. The interaction between p53 and papillomaviruses. Semin Cancer Biol. 1999;9:387-395. [PMID: 10712885 DOI: 10.1006/scbi.1999.0142] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
526 Allen-Hoffmann BL, Schlosser SJ, Ivarie CA, Sattler CA, Meisner LF, O'Connor SL. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol 2000;114:444-55. [PMID: 10692102 DOI: 10.1046/j.1523-1747.2000.00869.x] [Cited by in Crossref: 168] [Cited by in F6Publishing: 158] [Article Influence: 7.6] [Reference Citation Analysis]
527 Butel JS. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000;21:405-26. [PMID: 10688861 DOI: 10.1093/carcin/21.3.405] [Cited by in Crossref: 217] [Cited by in F6Publishing: 192] [Article Influence: 9.9] [Reference Citation Analysis]
528 Magnusson PK, Gyllensten UB. Cervical cancer risk: is there a genetic component? Molecular Medicine Today 2000;6:145-8. [DOI: 10.1016/s1357-4310(00)01685-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
529 Nakano Y, Naoe T, Kiyoi H, Kunishima S, Minami S, Miyawaki S, Asou N, Kuriyama K, Saito H, Ohno R. Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia. Leukemia Research 2000;24:349-52. [DOI: 10.1016/s0145-2126(99)00187-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
530 Caldeira S, de Villiers EM, Tommasino M. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein. Oncogene. 2000;19:821-826. [PMID: 10698500 DOI: 10.1038/sj.onc.1203375] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
531 Jackson S, Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 2000;19:592-8. [PMID: 10698529 DOI: 10.1038/sj.onc.1203339] [Cited by in Crossref: 149] [Cited by in F6Publishing: 135] [Article Influence: 6.8] [Reference Citation Analysis]
532 Marshall SE, Bordea C, Wojnarowska F, Morris PJ, Welsh KI. p53 CODON 72 POLYMORPHISM AND SUSCEPTIBILITY TO SKIN CANCER AFTER RENAL TRANSPLANTATION: . Transplantation. [DOI: 10.1097/00007890-200003150-00056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
533 Crum CP. Contemporary Theories of Cervical Carcinogenesis: The Virus, the Host, and the Stem Cell. Mod Pathol 2000;13:243-51. [DOI: 10.1038/modpathol.3880045] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
534 van Duin M, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, Verheijen RH, Helmerhorst TJ, Meijer CJ, Walboomers JM. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 2000;81:317-25. [PMID: 10644829 DOI: 10.1099/0022-1317-81-2-317] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 2.5] [Reference Citation Analysis]
535 Lukas J, Niu N, Press MF. p53 mutations and expression in breast carcinoma in situ. Am J Pathol 2000;156:183-91. [PMID: 10623666 DOI: 10.1016/S0002-9440(10)64718-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
536 Hagensee ME. Infection with human papillomavirus: Update on epidemiology, diagnosis, and treatment. Curr Infect Dis Rep 2000;2:18-24. [DOI: 10.1007/s11908-000-0083-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
537 Thomas M, Pim D, Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene. 1999;18:7690-7700. [PMID: 10618709 DOI: 10.1038/sj.onc.1202953] [Cited by in Crossref: 263] [Cited by in F6Publishing: 277] [Article Influence: 12.0] [Reference Citation Analysis]
538 May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene. 1999;18:7621-7636. [PMID: 10618702 DOI: 10.1038/sj.onc.1203285] [Cited by in Crossref: 397] [Cited by in F6Publishing: 400] [Article Influence: 18.0] [Reference Citation Analysis]
539 Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet. 1999;36:801-818. [PMID: 10544223 DOI: 10.1136/jmg.36.11.801] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
540 Magnusson PK, Lichtenstein P, Gyllensten UB. Heritability of cervical tumours. Int J Cancer 2000;88:698-701. [DOI: 10.1002/1097-0215(20001201)88:5<698::aid-ijc3>3.0.co;2-j] [Cited by in Crossref: 108] [Cited by in F6Publishing: 109] [Article Influence: 4.9] [Reference Citation Analysis]
541 Harwood CA, Surentheran T, Mcgregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000;61:289-97. [DOI: 10.1002/1096-9071(200007)61:3<289::aid-jmv2>3.0.co;2-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
542 Tong D, Kucera E, Stimpfl M, Kölbl H, Leodolter S, Zeillinger R. Detection of p53 Polymorphism at Codon 72 by PCR and Allele-specific Oligonucleotide Hybridization on Microtiter Plates. Clinical Chemistry 2000;46:124-6. [DOI: 10.1093/clinchem/46.1.124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
543 Malkin D, Brown EJ, Zipursky A. The Role of p53 in Megakaryocyte Differentiation and the Megakaryocytic Leukemias of Down Syndrome. Cancer Genetics and Cytogenetics 2000;116:1-5. [DOI: 10.1016/s0165-4608(99)00072-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
544 Lee J, Lee Y, Yang S, Shi W, Lee C, Luh S, Chen C, Hsieh C, Wu M. Genetic polymorphisms ofp53 andGSTP1,but notNAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 2000;89:458-64. [DOI: 10.1002/1097-0215(20000920)89:5<458::aid-ijc10>3.0.co;2-r] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 3.4] [Reference Citation Analysis]
545 Harwood CA, Surentheran T, Mcgregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000;61:289-97. [DOI: 10.1002/1096-9071(200007)61:3<289::aid-jmv2>3.0.co;2-z] [Cited by in Crossref: 306] [Cited by in F6Publishing: 261] [Article Influence: 13.9] [Reference Citation Analysis]
546 Makni H, Franco EL, Kaiano J, Villa LL, Labrecque S, Dudley R, Storey A, Matlashewski G. p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. Int J Cancer 2000;87:528-33. [DOI: 10.1002/1097-0215(20000815)87:4<528::aid-ijc11>3.0.co;2-o] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
547 Hemminki K, Kyyr�nen P. Familial cancer risks in affected sibships: Results from the Swedish Family-Cancer Database. Genet Epidemiol 2000;19:149-59. [DOI: 10.1002/1098-2272(200009)19:2<149::aid-gepi3>3.0.co;2-h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
548 Brady CS, Duggan-keen MF, Davidson JA, Varley JM, Stern PL. Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters. Journal of General Virology 1999;80:3233-40. [DOI: 10.1099/0022-1317-80-12-3233] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 1.9] [Reference Citation Analysis]
549 de Villiers E, Ruhland A, Šekaric P. Human papillomaviruses in non-melanoma skin cancer. Seminars in Cancer Biology 1999;9:413-22. [DOI: 10.1006/scbi.1999.0145] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
550 Sun Y, Keshava C, Sharp DS, Weston A, McCanlies EC. DNA sequence variants of p53: cancer and aging. Am J Hum Genet 1999;65:1779-82. [PMID: 10577934 DOI: 10.1086/302650] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
551 Gardiol D, Kühne C, Glaunsinger B, Lee SS, Javier R, Banks L. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 1999;18:5487-96. [PMID: 10523825 DOI: 10.1038/sj.onc.1202920] [Cited by in Crossref: 218] [Cited by in F6Publishing: 213] [Article Influence: 9.5] [Reference Citation Analysis]
552 Xirodimas DP, Lane DP. Molecular evolution of the thermosensitive PAb1620 epitope of human p53 by DNA shuffling. J Biol Chem 1999;274:28042-9. [PMID: 10488156 DOI: 10.1074/jbc.274.39.28042] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
553 Veldhoen N, Watterson J, Brash M, Milner J. Identification of tumour-associated and germ line p53 mutations in canine mammary cancer. Br J Cancer 1999;81:409-15. [PMID: 10507764 DOI: 10.1038/sj.bjc.6690709] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
554 Cass I, Baldwin RL, Karlan BY. Molecular advances in gynecologic oncology. Curr Opin Oncol 1999;11:394-400. [PMID: 10505778 DOI: 10.1097/00001622-199909000-00013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
555 Ndisang D, Budhram-mahadeo V, Latchman DS. The Brn-3a Transcription Factor Plays a Critical Role in Regulating Human Papilloma Virus Gene Expression and Determining the Growth Characteristics of Cervical Cancer Cells. Journal of Biological Chemistry 1999;274:28521-7. [DOI: 10.1074/jbc.274.40.28521] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 0.6] [Reference Citation Analysis]
556 Helland A, Børresen-dale A. p53 polymorphism and cervical cancer. The Lancet 1999;354:1561-2. [DOI: 10.1016/s0140-6736(05)76596-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
557 Giannoudis A, Graham DA, Southern SA, Herrington CS. p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix. Int J Cancer 1999;83:66-9. [DOI: 10.1002/(sici)1097-0215(19990924)83:1<66::aid-ijc13>3.0.co;2-k] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 1.2] [Reference Citation Analysis]
558 Ngan HY, Liu VW, Liu SS. Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer 1999;80:1828-9. [PMID: 10468305 DOI: 10.1038/sj.bjc.6690606] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
559 Harwood CA, McGregor JM, Proby CM, Breuer J. Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol 1999;52:249-53. [PMID: 10474513 DOI: 10.1136/jcp.52.4.249] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 2.8] [Reference Citation Analysis]
560 Bertorelle R, Chieco-bianchi L, Del Mistro A. Papillomavirus andp53 codon 72 polymorphism. Int J Cancer 1999;82:616-7. [DOI: 10.1002/(sici)1097-0215(19990812)82:4<616::aid-ijc24>3.0.co;2-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
561 Zehbe I, Voglino G, Wilander E, Genta F, Tommasino M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet. 1999;354:218-219. [PMID: 10421306 DOI: 10.1016/s0140-6736(99)01914-5] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 3.6] [Reference Citation Analysis]
562 Gimm O, Gössling A, Marsh DJ, Dahia PL, Mulligan LM, von Deimling A, Eng C. Mutation and deletion analysis of GFR alpha-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours. Br J Cancer 1999;80:383-6. [PMID: 10408842 DOI: 10.1038/sj.bjc.6690367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
563 Offner S, Schmaus W, Witter K, Baretton GB, Schlimok G, Passlick B, Riethmüller G, Pantel K. p53 gene mutations are not required for early dissemination of cancer cells. Proc Natl Acad Sci U S A 1999;96:6942-6. [PMID: 10359818 DOI: 10.1073/pnas.96.12.6942] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
564 Maciag P, Villa L. Genetic susceptibility to HPV infection and cervical cancer. Braz J Med Biol Res 1999;32:915-22. [DOI: 10.1590/s0100-879x1999000700017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
565 Mantovani F, Banks L. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines. Oncogene 1999;18:3309-15. [DOI: 10.1038/sj.onc.1202688] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
566 Wada I, Kanada H, Nomura K, Kato Y, Machinami R, Kitagawa T. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan. Hepatology 1999;29:1718-21. [PMID: 10347113 DOI: 10.1002/hep.510290635] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
567 Taylor JA, Tewari K, Liao SY, Hughes CCW, Villarreal LP. Immunohistochemical Analysis, Human Papillomavirus DNA Detection, Hormonal Manipulation, and Exogenous Gene Expression of Normal and Dysplastic Human Cervical Epithelium in Severe Combined Immunodeficiency Mice. J Virol 1999;73:5144-8. [DOI: 10.1128/jvi.73.6.5144-5148.1999] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
568 Prives C, Hall PA. The p53 pathway. J Pathol. 1999;187:112-126. [PMID: 10341712 DOI: 10.1002/(SICI)1096-9896(199901)187:1%3C112::AID-PATH250%3E3.0.CO;2-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
569 van Driel WJ, Kenter GG, Fleuren GJ, Melief CJ, Trimbos BJ. Immunotherapeutic strategies for cervical squamous carcinoma. Hematol Oncol Clin North Am 1999;13:259-73. [PMID: 10080080 DOI: 10.1016/s0889-8588(05)70164-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
570 Gillison ML, Koch WM, Shah KV. Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease?: . Current Opinion in Oncology 1999;11:191. [DOI: 10.1097/00001622-199905000-00010] [Cited by in Crossref: 92] [Cited by in F6Publishing: 79] [Article Influence: 4.0] [Reference Citation Analysis]
571 D'erchia A, Pesole G, Tullo A, Saccone C, Sbisà E. Guinea Pig p53 mRNA: Identification of New Elements in Coding and Untranslated Regions and Their Functional and Evolutionary Implications. Genomics 1999;58:50-64. [DOI: 10.1006/geno.1999.5794] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
572 Darnton SJ. Demystified ... p53. Mol Pathol 1998;51:248-53. [PMID: 10193518 DOI: 10.1136/mp.51.5.248] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
573 Kaelin WG. The emerging p53 gene family. J Natl Cancer Inst. 1999;91:594-598. [PMID: 10203277 DOI: 10.1093/jnci/91.7.594] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 4.1] [Reference Citation Analysis]
574 Sheppard HM, Corneillie SI, Espiritu C, Gatti A, Liu X. New insights into the mechanism of inhibition of P53 by simian virus 40 large Tantigen. Mol Cell Biol. 1999;19:2746-2753. [PMID: 10082540 DOI: 10.1128/MCB.19.4.2746] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
575 Mckenna, Murphy. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999;140:656-60. [DOI: 10.1046/j.1365-2133.1999.02765.x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 96] [Article Influence: 5.5] [Reference Citation Analysis]
576 Sonoda Y, Saigo PE, Boyd J. p53 and genetic susceptibility to cervical cancer. J Natl Cancer Inst 1999;91:557. [PMID: 10088627 DOI: 10.1093/jnci/91.6.557] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
577 Campo MS. HPV and cancer: the story unfolds. Trends Microbiol 1998;6:424-6. [PMID: 9846352 DOI: 10.1016/s0966-842x(98)01385-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
578 Ciechanover A. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 1998;17:7151-60. [PMID: 9857172 DOI: 10.1093/emboj/17.24.7151] [Cited by in Crossref: 943] [Cited by in F6Publishing: 941] [Article Influence: 41.0] [Reference Citation Analysis]
579 Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999;19:1092-100. [PMID: 9891044 DOI: 10.1128/MCB.19.2.1092] [Cited by in Crossref: 460] [Cited by in F6Publishing: 443] [Article Influence: 20.0] [Reference Citation Analysis]
580 Kühne C, Banks L. E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J Biol Chem 1998;273:34302-9. [PMID: 9852095 DOI: 10.1074/jbc.273.51.34302] [Cited by in Crossref: 122] [Cited by in F6Publishing: 114] [Article Influence: 5.3] [Reference Citation Analysis]
581 Song X, Sheppard HM, Norman AW, Liu X. Mitogen-activated Protein Kinase Is Involved in the Degradation of p53 Protein in the Bryostatin-1-induced Differentiation of the Acute Promyelocytic Leukemia NB4 Cell Line. Journal of Biological Chemistry 1999;274:1677-82. [DOI: 10.1074/jbc.274.3.1677] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
582 Day INM, Spanakis E, Chen X, O'dell SD. Microplate array diagonal gel electrophoresis for mutation research in DNA banks. Electrophoresis 1999;20:1250-7. [DOI: 10.1002/(sici)1522-2683(19990101)20:6<1250::aid-elps1250>3.0.co;2-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
583 Bonafè M, Olivieri F, Mari D, Baggio G, Mattace R, Sansoni P, De Benedictis G, De Luca M, Bertolini S, Barbi C, Monti D, Franceschi C. p53 variants predisposing to cancer are present in healthy centenarians. Am J Hum Genet 1999;64:292-5. [PMID: 9915969 DOI: 10.1086/302196] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
584 Prives C, Hall PA. The p53 pathway. J Pathol 1999;187:112-26. [DOI: 10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3] [Cited by in Crossref: 845] [Cited by in F6Publishing: 874] [Article Influence: 36.7] [Reference Citation Analysis]
585 Kutach LS, Bolshakov S, Ananthaswamy HN. Detection of mutations and polymorphisms in thep53 tumor suppressor gene by single-strand conformation polymorphism analysis. Electrophoresis 1999;20:1204-10. [DOI: 10.1002/(sici)1522-2683(19990101)20:6<1204::aid-elps1204>3.0.co;2-s] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
586 Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L. p53 polymorphism and risk of cervical cancer. Nature 1998;396:532-532. [DOI: 10.1038/25043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
587 Hildesheim A, Schiffman M, Brinton LA, Fraumeni JF, Herrero R, Bratti MC, Schwartz P, Mortel R, Barnes W, Greenberg M, Mcgowan L, Scott DR, Martin M, Herrera JE, Carrington M. p53 polymorphism and risk of cervical cancer. Nature 1998;396:531-2. [DOI: 10.1038/25040] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 2.5] [Reference Citation Analysis]
588 Helland Å, Langerød A, Johnsen H, Olsen AO, Skovlund E, Børresen-dale A. p53 polymorphism and risk of cervical cancer. Nature 1998;396:530-1. [DOI: 10.1038/25034] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 3.4] [Reference Citation Analysis]
589 Josefsson AM, Magnusson PKE, Ylitalo N, Quarforth-tubbin P, Pontén J, Adami HO, Gyllensten UB. p53 polymorphism and risk of cervical cancer. Nature 1998;396:531-531. [DOI: 10.1038/25037] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 2.2] [Reference Citation Analysis]
590 van der Zee AG, Hayes VM, Hofstra RM, Buys CH, Hollema H. Homozygous arginine-72 in wild type p53 and risk of cervical cancer. The Lancet 1998;352:1756. [DOI: 10.1016/s0140-6736(05)79829-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
591 Lanham S, Campbell I, Watt P, Gornall R. p53 polymorphism and risk of cervical cancer. The Lancet 1998;352:1631. [DOI: 10.1016/s0140-6736(05)61083-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 1.5] [Reference Citation Analysis]
592 Rosenthal AN, Ryan A, Al-jehani RM, Storey A, Harwood CA, Jacobs IJ. p53 codon 72 polymorphism and risk of cervical cancer in UK. The Lancet 1998;352:871-2. [DOI: 10.1016/s0140-6736(98)07357-7] [Cited by in Crossref: 108] [Cited by in F6Publishing: 118] [Article Influence: 4.5] [Reference Citation Analysis]
593 . p53 polymorphisms at position 72 and development of cervical cancer. Int J Gynecol Cancer 1998;8:439-439. [DOI: 10.1046/j.1525-1438.1998.0le05.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
594 zur Hausen H. Papillomavirus and p53. Nature 1998;393:217-217. [DOI: 10.1038/30363] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
595 Hallikeri K, Burde K, Anehosur V, Kulkarni BB, Hiremath SV. p53 polymorphism and association of human papillomavirus in oral submucous fibrosis and oral squamous cell carcinoma: A case-control study. J Oral Maxillofac Pathol 2019;23:97-103. [PMID: 31110424 DOI: 10.4103/jomfp.JOMFP_180_18] [Cited by in F6Publishing: 2] [Reference Citation Analysis]